id sid tid token lemma pos iajs-312 1 1 microsoft microsoft PROPN iajs-312 1 2 word word NOUN iajs-312 1 3 13 13 NUM iajs-312 1 4 470 470 NUM iajs-312 1 5 | | ADV iajs-312 1 6 chemistry chemistry NOUN iajs-312 1 7 2014 2014 NUM iajs-312 1 8 ) ) PUNCT iajs-312 1 9 عام عام ADP iajs-312 1 10 3(العدد 3(العدد NUM iajs-312 1 11 27المجلد 27المجلد NUM iajs-312 1 12 مجلة مجلة VERB iajs-312 1 13 إبن إبن NOUN iajs-312 1 14 الھيثم الھيثم NOUN iajs-312 1 15 للعلوم للعلوم NOUN iajs-312 1 16 الصرفة الصرفة NOUN iajs-312 2 1 و و PRON iajs-312 2 2 التطبيقية التطبيقية ADJ iajs-312 2 3 ibn ibn PROPN iajs-312 2 4 al al PROPN iajs-312 2 5 - - PUNCT iajs-312 2 6 haitham haitham PROPN iajs-312 2 7 jour jour X iajs-312 2 8 . . PROPN iajs-312 2 9 for for ADP iajs-312 2 10 pure pure ADJ iajs-312 2 11 & & CCONJ iajs-312 2 12 appl appl PROPN iajs-312 2 13 . . PUNCT iajs-312 3 1 sci sci PROPN iajs-312 3 2 . . PUNCT iajs-312 3 3 vol vol NOUN iajs-312 3 4 . . PROPN iajs-312 4 1 27 27 NUM iajs-312 4 2 ( ( PUNCT iajs-312 4 3 3 3 NUM iajs-312 4 4 ) ) PUNCT iajs-312 4 5 2014 2014 NUM iajs-312 4 6 determination determination NOUN iajs-312 4 7 of of ADP iajs-312 4 8 sialic sialic ADJ iajs-312 4 9 acid acid NOUN iajs-312 4 10 , , PUNCT iajs-312 4 11 paraoxonase-1and paraoxonase-1and ADJ iajs-312 4 12 igg igg PROPN iajs-312 4 13 levels level NOUN iajs-312 4 14 in in ADP iajs-312 4 15 patients patient NOUN iajs-312 4 16 with with ADP iajs-312 4 17 polycystic polycystic ADJ iajs-312 4 18 ovary ovary ADJ iajs-312 4 19 syndrome syndrome NOUN iajs-312 4 20 in in ADP iajs-312 4 21 messan messan ADJ iajs-312 4 22 female female ADJ iajs-312 4 23 patients patient NOUN iajs-312 4 24 ibtisam ibtisam PROPN iajs-312 4 25 k. k. PROPN iajs-312 4 26 mohaisn mohaisn VERB iajs-312 4 27 . . PUNCT iajs-312 5 1 biochemistry.collage biochemistry.collage NOUN iajs-312 5 2 of of ADP iajs-312 5 3 density/ density/ NUM iajs-312 5 4 university university NOUN iajs-312 5 5 of of ADP iajs-312 5 6 missan missan NOUN iajs-312 5 7 . . PUNCT iajs-312 6 1 zohair zohair PROPN iajs-312 6 2 i.al i.al PROPN iajs-312 6 3 mashhadani mashhadani PROPN iajs-312 6 4 dept dept PROPN iajs-312 6 5 . . PUNCT iajs-312 7 1 of of ADP iajs-312 7 2 chemistry/ chemistry/ NUM iajs-312 7 3 college college NOUN iajs-312 7 4 of of ADP iajs-312 7 5     SPACE iajs-312 7 6 education education NOUN iajs-312 7 7 for for ADP iajs-312 7 8 pure pure ADJ iajs-312 7 9 sciences/ sciences/ PROPN iajs-312 7 10 ( ( PUNCT iajs-312 7 11 ibn ibn PROPN iajs-312 7 12 – – PUNCT iajs-312 7 13 al al PROPN iajs-312 7 14 - - PUNCT iajs-312 7 15 haitham haitham PROPN iajs-312 7 16 ) ) PUNCT iajs-312 7 17 /university /university NOUN iajs-312 7 18 of of ADP iajs-312 7 19 baghdad baghdad PROPN iajs-312 7 20 . . PUNCT iajs-312 8 1 bushra bushra PROPN iajs-312 8 2 h. h. PROPN iajs-312 8 3 ali ali PROPN iajs-312 8 4 . . PUNCT iajs-312 9 1 dept dept PROPN iajs-312 9 2 . . PROPN iajs-312 10 1 of of ADP iajs-312 10 2 chemistry/ chemistry/ NUM iajs-312 10 3 college college NOUN iajs-312 10 4 of of ADP iajs-312 10 5     SPACE iajs-312 10 6 education education NOUN iajs-312 10 7 for for ADP iajs-312 10 8 pure pure ADJ iajs-312 10 9 sciences/ sciences/ PROPN iajs-312 10 10 ( ( PUNCT iajs-312 10 11 ibn ibn PROPN iajs-312 10 12 – – PUNCT iajs-312 10 13 al al PROPN iajs-312 10 14 - - PUNCT iajs-312 10 15 haitham haitham PROPN iajs-312 10 16 ) ) PUNCT iajs-312 10 17 /university /university NOUN iajs-312 10 18 of of ADP iajs-312 10 19 baghdad baghdad PROPN iajs-312 10 20 . . PUNCT iajs-312 11 1 drbushra750@yahoo.com drbushra750@yahoo.com X iajs-312 11 2 received receive VERB iajs-312 11 3 in in ADP iajs-312 11 4 : : PUNCT iajs-312 11 5 20 20 NUM iajs-312 11 6 may may AUX iajs-312 11 7 2014,accepted 2014,accepte VERB iajs-312 11 8 in in ADP iajs-312 11 9 : : PUNCT iajs-312 11 10 20 20 NUM iajs-312 11 11 october october NOUN iajs-312 11 12 2014 2014 NUM iajs-312 11 13 abstract abstract ADJ iajs-312 11 14 polycystic polycystic ADJ iajs-312 11 15 ovary ovary ADJ iajs-312 11 16 syndrome syndrome NOUN iajs-312 11 17 ( ( PUNCT iajs-312 11 18 pcos pcos PROPN iajs-312 11 19 ) ) PUNCT iajs-312 11 20 is be AUX iajs-312 11 21 a a DET iajs-312 11 22 heterogeneous heterogeneous ADJ iajs-312 11 23 disorder disorder NOUN iajs-312 11 24 . . PUNCT iajs-312 12 1 pcos pcos PROPN iajs-312 12 2 affects affect VERB iajs-312 12 3 6–10 6–10 NOUN iajs-312 12 4 % % NOUN iajs-312 12 5 of of ADP iajs-312 12 6 women woman NOUN iajs-312 12 7 during during ADP iajs-312 12 8 their their PRON iajs-312 12 9 reproductive reproductive ADJ iajs-312 12 10 life life NOUN iajs-312 12 11 . . PUNCT iajs-312 12 12     SPACE iajs-312 13 1 patients patient NOUN iajs-312 13 2 with with ADP iajs-312 13 3 pcos pco NOUN iajs-312 13 4 are be AUX iajs-312 13 5 in in ADP iajs-312 13 6 the the DET iajs-312 13 7 high high ADJ iajs-312 13 8 risk risk NOUN iajs-312 13 9 for for ADP iajs-312 13 10 coronary coronary ADJ iajs-312 13 11 heart heart NOUN iajs-312 13 12 disease disease NOUN iajs-312 13 13 because because SCONJ iajs-312 13 14 of of ADP iajs-312 13 15 their their PRON iajs-312 13 16 abnormal abnormal ADJ iajs-312 13 17 lipid lipid NOUN iajs-312 13 18 profile profile NOUN iajs-312 13 19 , , PUNCT iajs-312 13 20 insulin insulin NOUN iajs-312 13 21 resistance resistance NOUN iajs-312 13 22 and and CCONJ iajs-312 13 23 obesity obesity NOUN iajs-312 13 24 . . PUNCT iajs-312 14 1 the the DET iajs-312 14 2 present present ADJ iajs-312 14 3 study study NOUN iajs-312 14 4 aimed aim VERB iajs-312 14 5 to to PART iajs-312 14 6 shed shed VERB iajs-312 14 7 a a DET iajs-312 14 8 light light NOUN iajs-312 14 9 on on ADP iajs-312 14 10 the the DET iajs-312 14 11 contribution contribution NOUN iajs-312 14 12 of of ADP iajs-312 14 13 sialic sialic ADJ iajs-312 14 14 acid acid NOUN iajs-312 14 15 , , PUNCT iajs-312 14 16 paraoxonase paraoxonase NOUN iajs-312 14 17 and and CCONJ iajs-312 14 18 immunoglobulin immunoglobulin NOUN iajs-312 14 19 g g NOUN iajs-312 14 20 as as ADP iajs-312 14 21 a a DET iajs-312 14 22 clinical clinical ADJ iajs-312 14 23 indicator indicator NOUN iajs-312 14 24 in in ADP iajs-312 14 25 the the DET iajs-312 14 26 pathogenesis pathogenesis NOUN iajs-312 14 27 of of ADP iajs-312 14 28 pcos pcos PROPN iajs-312 14 29 . . PUNCT iajs-312 15 1 seventy seventy NUM iajs-312 15 2 five five NUM iajs-312 15 3 female female ADJ iajs-312 15 4 patients patient NOUN iajs-312 15 5 with with ADP iajs-312 15 6 age age NOUN iajs-312 15 7 range range NOUN iajs-312 15 8 ( ( PUNCT iajs-312 15 9 16 16 NUM iajs-312 15 10 - - SYM iajs-312 15 11 38 38 NUM iajs-312 15 12 ) ) PUNCT iajs-312 15 13 years year NOUN iajs-312 15 14 taken take VERB iajs-312 15 15 from from ADP iajs-312 15 16 al al PROPN iajs-312 15 17 - - PUNCT iajs-312 15 18 sadder sadder NOUN iajs-312 15 19     SPACE iajs-312 15 20 teaching teaching NOUN iajs-312 15 21 hospital hospital NOUN iajs-312 15 22 and and CCONJ iajs-312 15 23 alzahrawi alzahrawi VERB iajs-312 15 24 hospital hospital NOUN iajs-312 15 25 in in ADP iajs-312 15 26 governorate governorate NOUN iajs-312 15 27 of of ADP iajs-312 15 28 messan messan NOUN iajs-312 15 29 through through ADP iajs-312 15 30 the the DET iajs-312 15 31 period period NOUN iajs-312 15 32 from from ADP iajs-312 15 33 july july PROPN iajs-312 15 34 2013 2013 NUM iajs-312 15 35 to to ADP iajs-312 15 36 december december PROPN iajs-312 15 37 2013 2013 NUM iajs-312 15 38 and and CCONJ iajs-312 15 39 twenty twenty NUM iajs-312 15 40 five five NUM iajs-312 15 41 apparently apparently ADV iajs-312 15 42 health health NOUN iajs-312 15 43 subject subject NOUN iajs-312 15 44 as as ADP iajs-312 15 45 a a DET iajs-312 15 46 control control NOUN iajs-312 15 47 group group NOUN iajs-312 15 48 were be AUX iajs-312 15 49 enrolled enrol VERB iajs-312 15 50 in in ADP iajs-312 15 51 this this DET iajs-312 15 52 study study NOUN iajs-312 15 53 . . PUNCT iajs-312 16 1 the the DET iajs-312 16 2 patients patient NOUN iajs-312 16 3 were be AUX iajs-312 16 4 divided divide VERB iajs-312 16 5 into into ADP iajs-312 16 6 three three NUM iajs-312 16 7 groups group NOUN iajs-312 16 8 depending depend VERB iajs-312 16 9 on on ADP iajs-312 16 10 duration duration NOUN iajs-312 16 11 of of ADP iajs-312 16 12 pcos pcos PROPN iajs-312 16 13 , , PUNCT iajs-312 16 14 the the DET iajs-312 16 15 duration duration NOUN iajs-312 16 16 of of ADP iajs-312 16 17 groups group NOUN iajs-312 16 18 , , PUNCT iajs-312 16 19 g2 g2 PROPN iajs-312 16 20 range range VERB iajs-312 16 21 from from ADP iajs-312 16 22 3 3 NUM iajs-312 16 23 months month NOUN iajs-312 16 24 to to ADP iajs-312 16 25 12 12 NUM iajs-312 16 26 and and CCONJ iajs-312 16 27 group group NOUN iajs-312 16 28 g3 g3 PROPN iajs-312 16 29 from from ADP iajs-312 16 30 12 12 NUM iajs-312 16 31 months month NOUN iajs-312 16 32 to to ADP iajs-312 16 33 24 24 NUM iajs-312 16 34 months month NOUN iajs-312 16 35 and and CCONJ iajs-312 16 36 g4 g4 NOUN iajs-312 16 37 from from ADP iajs-312 16 38 24 24 NUM iajs-312 16 39 months month NOUN iajs-312 16 40 to to ADP iajs-312 16 41 48 48 NUM iajs-312 16 42 months month NOUN iajs-312 16 43 and and CCONJ iajs-312 16 44 more more ADJ iajs-312 16 45 . . PUNCT iajs-312 17 1 investigation investigation NOUN iajs-312 17 2 included include VERB iajs-312 17 3 estimation estimation NOUN iajs-312 17 4 of of ADP iajs-312 17 5 serum serum NOUN iajs-312 17 6 levels level NOUN iajs-312 17 7 of of ADP iajs-312 17 8 sialic sialic ADJ iajs-312 17 9 acid acid NOUN iajs-312 17 10 ( ( PUNCT iajs-312 17 11 sa sa PROPN iajs-312 17 12 ) ) PUNCT iajs-312 17 13 , , PUNCT iajs-312 17 14 paraoxonase paraoxonase NOUN iajs-312 17 15 ( ( PUNCT iajs-312 17 16 pon1 pon1 PROPN iajs-312 17 17 ) ) PUNCT iajs-312 17 18 and and CCONJ iajs-312 17 19 immunoglobulin immunoglobulin NOUN iajs-312 17 20 g g PROPN iajs-312 17 21 ( ( PUNCT iajs-312 17 22 igg igg PROPN iajs-312 17 23 ) ) PUNCT iajs-312 17 24 . . PUNCT iajs-312 18 1 serum serum PROPN iajs-312 18 2 sa sa PROPN iajs-312 18 3 levels level NOUN iajs-312 18 4 were be AUX iajs-312 18 5 highly highly ADV iajs-312 18 6 significant significant ADJ iajs-312 18 7 in in ADP iajs-312 18 8 pcos pcos NOUN iajs-312 18 9 patients patient NOUN iajs-312 18 10 as as SCONJ iajs-312 18 11 compared compare VERB iajs-312 18 12 with with ADP iajs-312 18 13 control control NOUN iajs-312 18 14 group group NOUN iajs-312 18 15 . . PUNCT iajs-312 19 1 also also ADV iajs-312 19 2 , , PUNCT iajs-312 19 3 significantly significantly ADV iajs-312 19 4 higher high ADJ iajs-312 19 5 were be AUX iajs-312 19 6 found find VERB iajs-312 19 7 between between ADP iajs-312 19 8 pon1 pon1 PROPN iajs-312 19 9 and and CCONJ iajs-312 19 10 igg igg PROPN iajs-312 19 11 with with ADP iajs-312 19 12 duration duration NOUN iajs-312 19 13 . . PUNCT iajs-312 20 1 conclusion conclusion NOUN iajs-312 20 2 from from ADP iajs-312 20 3 this this DET iajs-312 20 4 study study NOUN iajs-312 20 5 a a DET iajs-312 20 6 conclusion conclusion NOUN iajs-312 20 7 was be AUX iajs-312 20 8 drawn draw VERB iajs-312 20 9 that that SCONJ iajs-312 20 10 elevation elevation NOUN iajs-312 20 11 of of ADP iajs-312 20 12 concentration concentration NOUN iajs-312 20 13 of of ADP iajs-312 20 14 sialic sialic ADJ iajs-312 20 15 acid acid NOUN iajs-312 20 16 , , PUNCT iajs-312 20 17 pon1 pon1 PROPN iajs-312 20 18 and and CCONJ iajs-312 20 19 igg igg PROPN iajs-312 20 20 levels level NOUN iajs-312 20 21 can can AUX iajs-312 20 22 be be AUX iajs-312 20 23 useful useful ADJ iajs-312 20 24 in in ADP iajs-312 20 25 predict predict VERB iajs-312 20 26 risk risk NOUN iajs-312 20 27 for for ADP iajs-312 20 28 heart heart NOUN iajs-312 20 29 disease disease NOUN iajs-312 20 30 and and CCONJ iajs-312 21 1 dm dm X iajs-312 21 2 . . PUNCT iajs-312 22 1 key key ADJ iajs-312 22 2 words word NOUN iajs-312 22 3 : : PUNCT iajs-312 22 4 pcos pco NOUN iajs-312 22 5 , , PUNCT iajs-312 22 6 sialic sialic ADJ iajs-312 22 7 acid acid NOUN iajs-312 22 8 , , PUNCT iajs-312 22 9 pon1 pon1 PROPN iajs-312 22 10 , , PUNCT iajs-312 22 11 igg igg PROPN iajs-312 22 12 this this DET iajs-312 22 13 paper paper NOUN iajs-312 22 14 is be AUX iajs-312 22 15 part part NOUN iajs-312 22 16 of of ADP iajs-312 22 17 phd phd NOUN iajs-312 22 18 thesis thesis NOUN iajs-312 22 19 of of ADP iajs-312 22 20 the the DET iajs-312 22 21 first first ADJ iajs-312 22 22 author author NOUN iajs-312 22 23 471 471 NUM iajs-312 22 24 | | ADV iajs-312 22 25 chemistry chemistry NOUN iajs-312 22 26 2014 2014 NUM iajs-312 22 27 ) ) PUNCT iajs-312 22 28 عام عام ADP iajs-312 22 29 3(العدد 3(العدد NUM iajs-312 22 30 27المجلد 27المجلد NUM iajs-312 23 1 مجلة مجلة VERB iajs-312 23 2 إبن إبن NOUN iajs-312 23 3 الھيثم الھيثم NOUN iajs-312 23 4 للعلوم للعلوم NOUN iajs-312 23 5 الصرفة الصرفة NOUN iajs-312 24 1 و و PRON iajs-312 24 2 التطبيقية التطبيقية ADJ iajs-312 24 3 ibn ibn PROPN iajs-312 24 4 al al PROPN iajs-312 24 5 - - PUNCT iajs-312 24 6 haitham haitham PROPN iajs-312 24 7 jour jour X iajs-312 24 8 . . PROPN iajs-312 24 9 for for ADP iajs-312 24 10 pure pure ADJ iajs-312 24 11 & & CCONJ iajs-312 24 12 appl appl PROPN iajs-312 24 13 . . PUNCT iajs-312 25 1 sci sci PROPN iajs-312 25 2 . . PUNCT iajs-312 25 3 vol vol NOUN iajs-312 25 4 . . PROPN iajs-312 26 1 27 27 NUM iajs-312 26 2 ( ( PUNCT iajs-312 26 3 3 3 NUM iajs-312 26 4 ) ) PUNCT iajs-312 26 5 2014 2014 NUM iajs-312 26 6 introductin introductin NOUN iajs-312 26 7 polycystic polycystic ADJ iajs-312 26 8 ovary ovary ADJ iajs-312 26 9 syndrome syndrome NOUN iajs-312 26 10 is be AUX iajs-312 26 11 a a DET iajs-312 26 12 heterogeneous heterogeneous ADJ iajs-312 26 13 disorder disorder NOUN iajs-312 26 14 . . PUNCT iajs-312 27 1 pcos pcos PROPN iajs-312 27 2 affects affect VERB iajs-312 27 3 6–10 6–10 NOUN iajs-312 27 4 % % NOUN iajs-312 27 5 of of ADP iajs-312 27 6 women woman NOUN iajs-312 27 7 during during ADP iajs-312 27 8 their their PRON iajs-312 27 9 reproductive reproductive ADJ iajs-312 27 10 life life NOUN iajs-312 27 11 [ [ X iajs-312 27 12 1 1 NUM iajs-312 27 13 ] ] PUNCT iajs-312 27 14 . . PUNCT iajs-312 28 1 its its PRON iajs-312 28 2 complete complete ADJ iajs-312 28 3 phenotype phenotype NOUN iajs-312 28 4 is be AUX iajs-312 28 5 manifested manifest VERB iajs-312 28 6 by by ADP iajs-312 28 7 ovulatory ovulatory ADJ iajs-312 28 8 dysfunction dysfunction NOUN iajs-312 28 9 , , PUNCT iajs-312 28 10 hyperandrogenism hyperandrogenism NOUN iajs-312 28 11 and and CCONJ iajs-312 28 12 polycystic polycystic ADJ iajs-312 28 13 ovaries ovary NOUN iajs-312 28 14 [ [ X iajs-312 28 15 2 2 NUM iajs-312 28 16 ] ] PUNCT iajs-312 28 17 . . PUNCT iajs-312 29 1 patients patient NOUN iajs-312 29 2 with with ADP iajs-312 29 3 pcos pco NOUN iajs-312 29 4 are be AUX iajs-312 29 5 in in ADP iajs-312 29 6 the the DET iajs-312 29 7 high high ADJ iajs-312 29 8 risk risk NOUN iajs-312 29 9 group group NOUN iajs-312 29 10 for for ADP iajs-312 29 11 coronary coronary ADJ iajs-312 29 12 heart heart NOUN iajs-312 29 13 disease disease NOUN iajs-312 29 14 because because SCONJ iajs-312 29 15 of of ADP iajs-312 29 16 their their PRON iajs-312 29 17 abnormal abnormal ADJ iajs-312 29 18 lipid lipid NOUN iajs-312 29 19 profile profile NOUN iajs-312 29 20 , , PUNCT iajs-312 29 21 insulin insulin NOUN iajs-312 29 22 resistance resistance NOUN iajs-312 29 23 and and CCONJ iajs-312 29 24 obesity obesity NOUN iajs-312 29 25 [ [ X iajs-312 29 26 3 3 NUM iajs-312 29 27 ] ] PUNCT iajs-312 29 28 . . PUNCT iajs-312 30 1 sialic sialic ADJ iajs-312 30 2 acid acid PROPN iajs-312 30 3 ( ( PUNCT iajs-312 30 4 sa sa PROPN iajs-312 30 5 ) ) PUNCT iajs-312 30 6 , , PUNCT iajs-312 30 7 terminal terminal ADJ iajs-312 30 8 residue residue NOUN iajs-312 30 9 of of ADP iajs-312 30 10 the the DET iajs-312 30 11 oligosaccharide oligosaccharide NOUN iajs-312 30 12 side side NOUN iajs-312 30 13 chain chain NOUN iajs-312 30 14 of of ADP iajs-312 30 15 glycoproteins glycoprotein NOUN iajs-312 30 16 and and CCONJ iajs-312 30 17 glycolipids glycolipid NOUN iajs-312 30 18 , , PUNCT iajs-312 30 19 is be AUX iajs-312 30 20 a a DET iajs-312 30 21 cardiovascular cardiovascular ADJ iajs-312 30 22 risk risk NOUN iajs-312 30 23 factor factor NOUN iajs-312 30 24 known know VERB iajs-312 30 25 to to PART iajs-312 30 26 increase increase VERB iajs-312 30 27 in in ADP iajs-312 30 28 type type NOUN iajs-312 30 29 2 2 NUM iajs-312 30 30 diabetes diabetes NOUN iajs-312 30 31 mellitus mellitus NOUN iajs-312 31 1 [ [ X iajs-312 31 2 4].sialic 4].sialic NUM iajs-312 31 3 acid acid NOUN iajs-312 31 4 is be AUX iajs-312 31 5 involved involve VERB iajs-312 31 6 capillary capillary ADJ iajs-312 31 7 permeability permeability NOUN iajs-312 31 8 , , PUNCT iajs-312 31 9 platelet platelet NOUN iajs-312 31 10 aggregation aggregation NOUN iajs-312 31 11 and and CCONJ iajs-312 31 12 activity activity NOUN iajs-312 31 13 of of ADP iajs-312 31 14 enzymes enzyme NOUN iajs-312 31 15 , , PUNCT iajs-312 31 16 by by ADP iajs-312 31 17 antigenetic antigenetic ADJ iajs-312 31 18 activity activity NOUN iajs-312 31 19 and and CCONJ iajs-312 31 20 receptor receptor NOUN iajs-312 31 21 function function NOUN iajs-312 31 22 [ [ X iajs-312 31 23 5 5 NUM iajs-312 31 24 ] ] PUNCT iajs-312 31 25 . . PUNCT iajs-312 32 1 sialic sialic ADJ iajs-312 32 2 acid acid NOUN iajs-312 32 3 binding bind VERB iajs-312 32 4 immunoglobulins immunoglobulin NOUN iajs-312 32 5 ( ( PUNCT iajs-312 32 6 ig)-like ig)-like INTJ iajs-312 32 7 lectins lectin NOUN iajs-312 32 8 ( ( PUNCT iajs-312 32 9 siglecs siglec NOUN iajs-312 32 10 ) ) PUNCT iajs-312 32 11 belong belong VERB iajs-312 32 12 to to ADP iajs-312 32 13 i i NOUN iajs-312 32 14 - - PUNCT iajs-312 32 15 type type NOUN iajs-312 32 16 lectin lectin NOUN iajs-312 32 17 with with ADP iajs-312 32 18 a a DET iajs-312 32 19 selective selective ADJ iajs-312 32 20 expression expression NOUN iajs-312 32 21 on on ADP iajs-312 32 22 the the DET iajs-312 32 23 haematopoetic haematopoetic ADJ iajs-312 32 24 cell cell NOUN iajs-312 32 25 lineages lineage NOUN iajs-312 32 26 [ [ X iajs-312 32 27 6 6 NUM iajs-312 32 28 ] ] PUNCT iajs-312 32 29 . . PUNCT iajs-312 33 1 the the DET iajs-312 33 2 fraction fraction NOUN iajs-312 33 3 of of ADP iajs-312 33 4 igg igg PROPN iajs-312 33 5 that that PRON iajs-312 33 6 is be AUX iajs-312 33 7 α-2,6 α-2,6 PROPN iajs-312 33 8 - - PUNCT iajs-312 33 9 sialylated sialylate VERB iajs-312 33 10 exhibits exhibit VERB iajs-312 33 11 anti anti ADJ iajs-312 33 12 - - ADJ iajs-312 33 13 inflammatory inflammatory ADJ iajs-312 33 14 activity activity NOUN iajs-312 33 15 and and CCONJ iajs-312 33 16 sialylation sialylation NOUN iajs-312 33 17 is be AUX iajs-312 33 18 proposed propose VERB iajs-312 33 19 to to PART iajs-312 33 20 enable enable VERB iajs-312 33 21 binding bind VERB iajs-312 33 22 to to ADP iajs-312 33 23 the the DET iajs-312 33 24 cell cell NOUN iajs-312 33 25 surface surface NOUN iajs-312 33 26 lectin lectin NOUN iajs-312 33 27 , , PUNCT iajs-312 33 28 dendritic dendritic ADJ iajs-312 33 29 cell cell NOUN iajs-312 33 30 - - PUNCT iajs-312 33 31 specific specific ADJ iajs-312 33 32 intercellular intercellular ADJ iajs-312 33 33 adhesion adhesion NOUN iajs-312 33 34 molecule3 molecule3 NOUN iajs-312 33 35 - - PUNCT iajs-312 33 36 grabbing grab VERB iajs-312 33 37     SPACE iajs-312 33 38 nonintegrin nonintegrin NOUN iajs-312 33 39 ( ( PUNCT iajs-312 33 40 dcsign dcsign NOUN iajs-312 33 41 ) ) PUNCT iajs-312 34 1 [ [ X iajs-312 34 2 7 7 NUM iajs-312 34 3 ] ] PUNCT iajs-312 34 4 . . PUNCT iajs-312 35 1 the the DET iajs-312 35 2 mechanism mechanism NOUN iajs-312 35 3 to to PART iajs-312 35 4     SPACE iajs-312 35 5 explain explain VERB iajs-312 35 6 the the DET iajs-312 35 7 putative putative ADJ iajs-312 35 8 sialic sialic ADJ iajs-312 35 9 acid acid NOUN iajs-312 35 10 - - PUNCT iajs-312 35 11 dependent dependent ADJ iajs-312 35 12 binding binding NOUN iajs-312 35 13 of of ADP iajs-312 35 14 igg igg PROPN iajs-312 35 15 , , PUNCT iajs-312 35 16 fc fc PROPN iajs-312 35 17 to to ADP iajs-312 35 18 dc dc PROPN iajs-312 35 19 - - PUNCT iajs-312 35 20 sign sign NOUN iajs-312 35 21 , , PUNCT iajs-312 35 22 as as ADV iajs-312 35 23 well well ADV iajs-312 35 24 as as ADP iajs-312 35 25 to to ADP iajs-312 35 26 the the DET iajs-312 35 27 ige ige PROPN iajs-312 35 28 receptor receptor NOUN iajs-312 35 29 , , PUNCT iajs-312 35 30 cd23 cd23 PROPN iajs-312 35 31 [ [ X iajs-312 35 32 8 8 NUM iajs-312 35 33 ] ] PUNCT iajs-312 35 34 . . PUNCT iajs-312 36 1 previous previous ADJ iajs-312 36 2 studies study NOUN iajs-312 36 3 showed show VERB iajs-312 36 4 that that SCONJ iajs-312 36 5 interactions interaction NOUN iajs-312 36 6 between between ADP iajs-312 36 7 siglecs siglec NOUN iajs-312 36 8 and and CCONJ iajs-312 36 9 sialic sialic ADJ iajs-312 36 10 acids acid NOUN iajs-312 36 11 are be AUX iajs-312 36 12 involved involve VERB iajs-312 36 13 in in ADP iajs-312 36 14 host host NOUN iajs-312 36 15 - - PUNCT iajs-312 36 16 pathogen pathogen NOUN iajs-312 36 17 interactions interaction NOUN iajs-312 36 18 as as ADV iajs-312 36 19 well well ADV iajs-312 36 20 as as ADP iajs-312 36 21 in in ADP iajs-312 36 22 host host NOUN iajs-312 36 23 self self NOUN iajs-312 36 24 - - PUNCT iajs-312 36 25 recognition recognition NOUN iajs-312 37 1 [ [ X iajs-312 37 2 9 9 NUM iajs-312 37 3 ] ] PUNCT iajs-312 37 4 . . PUNCT iajs-312 38 1 accumulating accumulate VERB iajs-312 38 2 evidence evidence NOUN iajs-312 38 3 indicates indicate VERB iajs-312 38 4 that that SCONJ iajs-312 38 5 siglecs siglec NOUN iajs-312 38 6 play play VERB iajs-312 38 7 critical critical ADJ iajs-312 38 8 roles role NOUN iajs-312 38 9 in in ADP iajs-312 38 10 immune immune ADJ iajs-312 38 11 signaling signaling NOUN iajs-312 38 12 and and CCONJ iajs-312 38 13 functions function NOUN iajs-312 38 14 . . PUNCT iajs-312 39 1 sialic sialic ADJ iajs-312 39 2 acid acid NOUN iajs-312 39 3 in in ADP iajs-312 39 4 the the DET iajs-312 39 5 human human ADJ iajs-312 39 6 body body NOUN iajs-312 39 7 are be AUX iajs-312 39 8 mainly mainly ADV iajs-312 39 9 found find VERB iajs-312 39 10 interminal interminal ADJ iajs-312 39 11 oligosaccharide oligosaccharide NOUN iajs-312 39 12 of of ADP iajs-312 39 13 glycoprotein glycoprotein NOUN iajs-312 39 14 in in ADP iajs-312 39 15 structure structure NOUN iajs-312 39 16 acute acute NOUN iajs-312 39 17 phase phase NOUN iajs-312 39 18 reactants reactant VERB iajs-312 39 19 their their PRON iajs-312 39 20 concentrations concentration NOUN iajs-312 39 21 increase increase VERB iajs-312 39 22 rapidly rapidly ADV iajs-312 39 23 at at ADP iajs-312 39 24 the the DET iajs-312 39 25 beginning beginning NOUN iajs-312 39 26 of of ADP iajs-312 39 27 inflammatory inflammatory ADJ iajs-312 39 28 reaction reaction NOUN iajs-312 39 29 [ [ X iajs-312 39 30 10 10 NUM iajs-312 39 31 ] ] PUNCT iajs-312 39 32 . . PUNCT iajs-312 40 1 paraoxonase-1 paraoxonase-1 NUM iajs-312 40 2 ( ( PUNCT iajs-312 40 3 pon-1 pon-1 X iajs-312 40 4 ) ) PUNCT iajs-312 40 5 , , PUNCT iajs-312 40 6 is be AUX iajs-312 40 7 an an DET iajs-312 40 8 enzyme enzyme NOUN iajs-312 40 9 synthesized synthesize VERB iajs-312 40 10 in in ADP iajs-312 40 11 the the DET iajs-312 40 12 liver liver NOUN iajs-312 40 13 [ [ X iajs-312 40 14 11 11 NUM iajs-312 40 15 ] ] PUNCT iajs-312 40 16 . . PUNCT iajs-312 41 1 serum serum PROPN iajs-312 41 2 pno1 pno1 PROPN iajs-312 41 3 activiy activiy PROPN iajs-312 41 4 was be AUX iajs-312 41 5 found find VERB iajs-312 41 6 to to PART iajs-312 41 7 be be AUX iajs-312 41 8 reduced reduce VERB iajs-312 41 9 in in ADP iajs-312 41 10 a a DET iajs-312 41 11 number number NOUN iajs-312 41 12 of of ADP iajs-312 41 13 pathological pathological ADJ iajs-312 41 14 conditions condition NOUN iajs-312 41 15 including include VERB iajs-312 41 16 coronary coronary ADJ iajs-312 41 17 artery artery NOUN iajs-312 41 18 disease disease NOUN iajs-312 42 1 [ [ X iajs-312 42 2 12 12 NUM iajs-312 42 3 ] ] PUNCT iajs-312 42 4 , , PUNCT iajs-312 42 5 hypercholesterolemia hypercholesterolemia NOUN iajs-312 42 6 , , PUNCT iajs-312 42 7 type type NOUN iajs-312 42 8 2 2 NUM iajs-312 42 9 diabets diabet NOUN iajs-312 42 10 , , PUNCT iajs-312 42 11 polycystic polycystic ADJ iajs-312 42 12 ovary ovary ADJ iajs-312 42 13 syndrome syndrome NOUN iajs-312 43 1 [ [ X iajs-312 43 2 13 13 NUM iajs-312 43 3 ] ] PUNCT iajs-312 43 4 , , PUNCT iajs-312 43 5 and and CCONJ iajs-312 43 6 renal renal ADJ iajs-312 43 7 failure failure NOUN iajs-312 43 8 [ [ X iajs-312 43 9 14 14 NUM iajs-312 43 10 ] ] PUNCT iajs-312 43 11 . . PUNCT iajs-312 44 1 pon1 pon1 PROPN iajs-312 44 2 is be AUX iajs-312 44 3 recognized recognize VERB iajs-312 44 4 as as ADP iajs-312 44 5 an an DET iajs-312 44 6 antioxidant antioxidant ADJ iajs-312 44 7 enzyme enzyme NOUN iajs-312 44 8 because because SCONJ iajs-312 44 9 it it PRON iajs-312 44 10 hydrolyzes hydrolyze VERB iajs-312 44 11 lipid lipid NOUN iajs-312 44 12 peroxides peroxide NOUN iajs-312 44 13 in in ADP iajs-312 44 14 oxidized oxidized ADJ iajs-312 44 15 lipoproteins lipoprotein NOUN iajs-312 44 16 [ [ X iajs-312 44 17 15 15 NUM iajs-312 44 18 ] ] PUNCT iajs-312 44 19 , , PUNCT iajs-312 44 20 and and CCONJ iajs-312 44 21 increases increase VERB iajs-312 44 22 the the DET iajs-312 44 23 risk risk NOUN iajs-312 44 24 factors factor NOUN iajs-312 44 25 for for ADP iajs-312 44 26 cardiovascular cardiovascular ADJ iajs-312 44 27 disease disease NOUN iajs-312 45 1 [ [ X iajs-312 45 2 16 16 NUM iajs-312 45 3 ] ] PUNCT iajs-312 45 4 , , PUNCT iajs-312 45 5 including include VERB iajs-312 45 6 hyperandrogenism hyperandrogenism NOUN iajs-312 45 7 ( ( PUNCT iajs-312 45 8 ha ha INTJ iajs-312 45 9 ) ) PUNCT iajs-312 45 10 , , PUNCT iajs-312 45 11 impaired impaired ADJ iajs-312 45 12 fibrinolysis fibrinolysis NOUN iajs-312 45 13 , , PUNCT iajs-312 45 14 increased increase VERB iajs-312 45 15 systemic systemic ADJ iajs-312 45 16 low low ADJ iajs-312 45 17 grade grade NOUN iajs-312 45 18 inflammation inflammation NOUN iajs-312 45 19 , , PUNCT iajs-312 45 20 an an DET iajs-312 45 21 elevated elevated ADJ iajs-312 45 22 prevalence prevalence NOUN iajs-312 45 23 of of ADP iajs-312 45 24 subclinical subclinical ADJ iajs-312 45 25 and and CCONJ iajs-312 45 26 clinical clinical ADJ iajs-312 45 27 atherosclerosis atherosclerosis NOUN iajs-312 45 28 [ [ X iajs-312 45 29 16 16 NUM iajs-312 45 30 , , PUNCT iajs-312 45 31 17 17 NUM iajs-312 45 32 ] ] PUNCT iajs-312 45 33 . . PUNCT iajs-312 46 1 the the DET iajs-312 46 2 enzyme enzyme NOUN iajs-312 46 3 not not PART iajs-312 46 4 only only ADV iajs-312 46 5 hydrolyzes hydrolyze VERB iajs-312 46 6 several several ADJ iajs-312 46 7 organo organo ADJ iajs-312 46 8 phosphorus phosphorus NOUN iajs-312 46 9 insecticides insecticide NOUN iajs-312 46 10 and and CCONJ iajs-312 46 11 nerve nerve NOUN iajs-312 46 12 agents agent NOUN iajs-312 46 13 , , PUNCT iajs-312 46 14 which which PRON iajs-312 46 15 is be AUX iajs-312 46 16 involved involve VERB iajs-312 46 17 in in ADP iajs-312 46 18 the the DET iajs-312 46 19 protection protection NOUN iajs-312 46 20 against against ADP iajs-312 46 21 xenobiotic xenobiotic ADJ iajs-312 46 22 toxicity toxicity NOUN iajs-312 46 23 [ [ X iajs-312 46 24 18 18 NUM iajs-312 46 25 ] ] X iajs-312 46 26 ] ] PUNCT iajs-312 46 27 , , PUNCT iajs-312 46 28 but but CCONJ iajs-312 46 29 also also ADV iajs-312 46 30 inhibits inhibit VERB iajs-312 46 31 ldl ldl NOUN iajs-312 46 32 oxidation oxidation NOUN iajs-312 46 33 , , PUNCT iajs-312 46 34 increases increase VERB iajs-312 46 35 macrophage macrophage ADJ iajs-312 46 36 - - PUNCT iajs-312 46 37 associated associate VERB iajs-312 46 38 cholesterol cholesterol NOUN iajs-312 46 39 efflux efflux NOUN iajs-312 46 40 , , PUNCT iajs-312 46 41 and and CCONJ iajs-312 46 42 possesses possess VERB iajs-312 46 43 antioxidant antioxidant ADJ iajs-312 46 44 , , PUNCT iajs-312 46 45 anti anti ADJ iajs-312 46 46 - - ADJ iajs-312 46 47 inflammatory inflammatory ADJ iajs-312 46 48 , , PUNCT iajs-312 46 49 and and CCONJ iajs-312 46 50 antiatherogentic antiatherogentic ADJ iajs-312 46 51 properties property NOUN iajs-312 46 52 [ [ X iajs-312 46 53 19 19 NUM iajs-312 46 54 ] ] PUNCT iajs-312 46 55 . . PUNCT iajs-312 47 1 recent recent ADJ iajs-312 47 2 studies study NOUN iajs-312 47 3 show show VERB iajs-312 47 4 that that SCONJ iajs-312 47 5 the the DET iajs-312 47 6 lactonase lactonase NOUN iajs-312 47 7 activity activity NOUN iajs-312 47 8 of of ADP iajs-312 47 9 pon1 pon1 NOUN iajs-312 47 10 could could AUX iajs-312 47 11 play play VERB iajs-312 47 12 important important ADJ iajs-312 47 13 roles role NOUN iajs-312 47 14 in in ADP iajs-312 47 15 hydrolyzing hydrolyzing NOUN iajs-312 47 16 and and CCONJ iajs-312 47 17 detoxifying detoxifying NOUN iajs-312 47 18 oxidative oxidative ADJ iajs-312 47 19 stress stress NOUN iajs-312 47 20 mediators mediator NOUN iajs-312 47 21 and and CCONJ iajs-312 47 22 inhibit inhibit VERB iajs-312 47 23 homocysteinylation homocysteinylation NOUN iajs-312 47 24 of of ADP iajs-312 47 25 protein protein NOUN iajs-312 47 26 , , PUNCT iajs-312 47 27 which which PRON iajs-312 47 28 could could AUX iajs-312 47 29 be be AUX iajs-312 47 30 involved involve VERB iajs-312 47 31 in in ADP iajs-312 47 32 protecting protect VERB iajs-312 47 33 against against ADP iajs-312 47 34 protein protein NOUN iajs-312 47 35 inactivation inactivation NOUN iajs-312 47 36 , , PUNCT iajs-312 47 37 cell cell NOUN iajs-312 47 38 damage damage NOUN iajs-312 47 39 and and CCONJ iajs-312 47 40 atherosclerosis atherosclerosis NOUN iajs-312 47 41 [ [ X iajs-312 47 42 18 18 NUM iajs-312 47 43 ] ] PUNCT iajs-312 47 44 . . PUNCT iajs-312 48 1 aim aim NOUN iajs-312 48 2 of of ADP iajs-312 48 3 this this DET iajs-312 48 4 study study NOUN iajs-312 48 5 the the DET iajs-312 48 6 present present ADJ iajs-312 48 7 study study NOUN iajs-312 48 8 aimed aim VERB iajs-312 48 9 to to ADP iajs-312 48 10 determination determination NOUN iajs-312 48 11 sialic sialic PROPN iajs-312 48 12 acid acid PROPN iajs-312 48 13 , , PUNCT iajs-312 48 14 paraxonase paraxonase NOUN iajs-312 48 15 -1 -1 PUNCT iajs-312 48 16 and and CCONJ iajs-312 48 17 immunoglobulin immunoglobulin NOUN iajs-312 48 18 g g PROPN iajs-312 48 19 as as ADP iajs-312 48 20 anti anti X iajs-312 48 21 inflammatory inflammatory ADJ iajs-312 48 22 in in ADP iajs-312 48 23 pcos pcos NOUN iajs-312 48 24 patients patient NOUN iajs-312 48 25 which which PRON iajs-312 48 26 can can AUX iajs-312 48 27 be be AUX iajs-312 48 28 pride pride NOUN iajs-312 48 29 the the DET iajs-312 48 30 risk risk NOUN iajs-312 48 31 for for ADP iajs-312 48 32 heart heart NOUN iajs-312 48 33 disease disease NOUN iajs-312 48 34 and and CCONJ iajs-312 48 35 dm dm PRON iajs-312 48 36 clinical clinical ADJ iajs-312 48 37 indicator indicator NOUN iajs-312 48 38 of of ADP iajs-312 48 39 polycystic polycystic ADJ iajs-312 48 40 ovary ovary ADJ iajs-312 48 41 syndromes syndrome NOUN iajs-312 48 42 . . PUNCT iajs-312 49 1 472 472 NUM iajs-312 49 2 | | ADV iajs-312 49 3 chemistry chemistry NOUN iajs-312 49 4 2014 2014 NUM iajs-312 49 5 ) ) PUNCT iajs-312 49 6 عام عام ADP iajs-312 49 7 3(العدد 3(العدد NUM iajs-312 49 8 27المجلد 27المجلد NUM iajs-312 49 9 مجلة مجلة VERB iajs-312 49 10 إبن إبن NOUN iajs-312 49 11 الھيثم الھيثم NOUN iajs-312 49 12 للعلوم للعلوم NOUN iajs-312 49 13 الصرفة الصرفة NOUN iajs-312 50 1 و و PRON iajs-312 50 2 التطبيقية التطبيقية ADJ iajs-312 50 3 ibn ibn PROPN iajs-312 50 4 al al PROPN iajs-312 50 5 - - PUNCT iajs-312 50 6 haitham haitham PROPN iajs-312 50 7 jour jour X iajs-312 50 8 . . PROPN iajs-312 50 9 for for ADP iajs-312 50 10 pure pure ADJ iajs-312 50 11 & & CCONJ iajs-312 50 12 appl appl PROPN iajs-312 50 13 . . PUNCT iajs-312 51 1 sci sci PROPN iajs-312 51 2 . . PUNCT iajs-312 51 3 vol vol NOUN iajs-312 51 4 . . PROPN iajs-312 52 1 27 27 NUM iajs-312 52 2 ( ( PUNCT iajs-312 52 3 3 3 NUM iajs-312 52 4 ) ) PUNCT iajs-312 52 5 2014 2014 NUM iajs-312 52 6 material material NOUN iajs-312 52 7 and and CCONJ iajs-312 52 8 method method VERB iajs-312 52 9 five five NUM iajs-312 52 10 ml ml NOUN iajs-312 52 11 of of ADP iajs-312 52 12 blood blood NOUN iajs-312 52 13 were be AUX iajs-312 52 14 drawn draw VERB iajs-312 52 15 from from ADP iajs-312 52 16 all all DET iajs-312 52 17 subjects subject NOUN iajs-312 52 18 enrolled enrol VERB iajs-312 52 19 in in ADP iajs-312 52 20 this this DET iajs-312 52 21 study study NOUN iajs-312 52 22 , , PUNCT iajs-312 52 23 and and CCONJ iajs-312 52 24 kept keep VERB iajs-312 52 25 in in ADP iajs-312 52 26 plain plain ADJ iajs-312 52 27 tubes tube NOUN iajs-312 52 28 left leave VERB iajs-312 52 29 to to PART iajs-312 52 30 clot clot NOUN iajs-312 52 31 at at ADP iajs-312 52 32 room room NOUN iajs-312 52 33 temperature temperature NOUN iajs-312 52 34 for for ADP iajs-312 52 35 15 15 NUM iajs-312 52 36 min min NOUN iajs-312 52 37 . . PROPN iajs-312 52 38 then then ADV iajs-312 52 39     SPACE iajs-312 52 40 centrifuged centrifuge VERB iajs-312 52 41 at at ADP iajs-312 52 42 3500 3500 NUM iajs-312 52 43 g g NOUN iajs-312 52 44 for for ADP iajs-312 52 45 10 10 NUM iajs-312 52 46 min min NOUN iajs-312 52 47 to to PART iajs-312 52 48 separate separate VERB iajs-312 52 49 the the DET iajs-312 52 50 serum serum NOUN iajs-312 52 51 . . PUNCT iajs-312 53 1 subjects subject NOUN iajs-312 53 2 the the DET iajs-312 53 3 present present ADJ iajs-312 53 4 study study NOUN iajs-312 53 5 was be AUX iajs-312 53 6 performed perform VERB iajs-312 53 7 on on ADP iajs-312 53 8 a a DET iajs-312 53 9 group group NOUN iajs-312 53 10 of of ADP iajs-312 53 11 100 100 NUM iajs-312 53 12 female female ADJ iajs-312 53 13 patients patient NOUN iajs-312 53 14 with with ADP iajs-312 53 15 pcos pcos PROPN iajs-312 53 16 from from ADP iajs-312 53 17 messan messan PROPN iajs-312 53 18 , , PUNCT iajs-312 53 19 al al PROPN iajs-312 53 20 - - PUNCT iajs-312 53 21 sadder sadder NOUN iajs-312 53 22     SPACE iajs-312 53 23 teaching teaching NOUN iajs-312 53 24 hospital hospital NOUN iajs-312 53 25 and and CCONJ iajs-312 53 26 al al PROPN iajs-312 53 27 - - PUNCT iajs-312 53 28 zahrawi zahrawi PROPN iajs-312 53 29 hospital hospital NOUN iajs-312 53 30 during during ADP iajs-312 53 31 july july PROPN iajs-312 53 32 2013 2013 NUM iajs-312 53 33 to to ADP iajs-312 53 34 december december PROPN iajs-312 53 35 2013.they 2013.they NUM iajs-312 53 36 were be AUX iajs-312 53 37 diagnosed diagnose VERB iajs-312 53 38 by by ADP iajs-312 53 39 physician physician NOUN iajs-312 53 40 at at ADP iajs-312 53 41 the the DET iajs-312 53 42 hospital hospital NOUN iajs-312 53 43 using use VERB iajs-312 53 44 ultra ultra ADJ iajs-312 53 45 sound sound NOUN iajs-312 53 46 .the .the SCONJ iajs-312 53 47 patients patient NOUN iajs-312 53 48 were be AUX iajs-312 53 49 divided divide VERB iajs-312 53 50 into into ADP iajs-312 53 51 three three NUM iajs-312 53 52 groups group NOUN iajs-312 53 53 depending depend VERB iajs-312 53 54 on on ADP iajs-312 53 55 duration duration NOUN iajs-312 53 56 of of ADP iajs-312 53 57 pcos pcos PROPN iajs-312 53 58 , , PUNCT iajs-312 53 59 which which PRON iajs-312 53 60 the the DET iajs-312 53 61 duration duration NOUN iajs-312 53 62 of of ADP iajs-312 53 63 ( ( PUNCT iajs-312 53 64 g2 g2 PROPN iajs-312 53 65 ) ) PUNCT iajs-312 53 66 from from ADP iajs-312 53 67 3 3 NUM iajs-312 53 68 monthes monthe NOUN iajs-312 53 69 to to ADP iajs-312 53 70 12 12 NUM iajs-312 53 71 months month NOUN iajs-312 53 72 , , PUNCT iajs-312 53 73 ( ( PUNCT iajs-312 53 74 g3 g3 NOUN iajs-312 53 75 ) ) PUNCT iajs-312 53 76 from from ADP iajs-312 53 77 12 12 NUM iajs-312 53 78 months month NOUN iajs-312 53 79 to to ADP iajs-312 53 80 24 24 NUM iajs-312 53 81 months month NOUN iajs-312 53 82 , , PUNCT iajs-312 53 83 ( ( PUNCT iajs-312 53 84 g4 g4 NOUN iajs-312 53 85 ) ) PUNCT iajs-312 53 86 from from ADP iajs-312 53 87 24 24 NUM iajs-312 53 88 to to PART iajs-312 53 89 36 36 NUM iajs-312 53 90 months month NOUN iajs-312 53 91 and and CCONJ iajs-312 53 92 more more ADJ iajs-312 53 93 . . PUNCT iajs-312 54 1 in in ADP iajs-312 54 2 addition addition NOUN iajs-312 54 3 , , PUNCT iajs-312 54 4 to to ADP iajs-312 54 5 group group NOUN iajs-312 54 6 ( ( PUNCT iajs-312 54 7 g1 g1 PROPN iajs-312 54 8 ) ) PUNCT iajs-312 54 9 25 25 NUM iajs-312 54 10 healthy healthy ADJ iajs-312 54 11 individuals individual NOUN iajs-312 54 12 were be AUX iajs-312 54 13 enrolled enrol VERB iajs-312 54 14 in in ADP iajs-312 54 15 the the DET iajs-312 54 16 study study NOUN iajs-312 54 17 as as ADP iajs-312 54 18 a a DET iajs-312 54 19 control control NOUN iajs-312 54 20 group group NOUN iajs-312 54 21 g1 g1 NOUN iajs-312 54 22 . . PUNCT iajs-312 55 1 sialic sialic ADJ iajs-312 55 2 acid acid NOUN iajs-312 55 3 and and CCONJ iajs-312 55 4 pon-1 pon-1 PUNCT iajs-312 55 5 determinations determination NOUN iajs-312 55 6 sialic sialic ADJ iajs-312 55 7 acid acid NOUN iajs-312 55 8 and and CCONJ iajs-312 55 9 pon-1 pon-1 PUNCT iajs-312 55 10 have have AUX iajs-312 55 11 been be AUX iajs-312 55 12 estimated estimate VERB iajs-312 55 13 by by ADP iajs-312 55 14 using use VERB iajs-312 55 15 enzyme enzyme NOUN iajs-312 55 16 linked link VERB iajs-312 55 17 immuno immuno ADJ iajs-312 55 18 sorbent sorbent NOUN iajs-312 55 19 assay assay NOUN iajs-312 55 20 ( ( PUNCT iajs-312 55 21 elisa elisa NOUN iajs-312 55 22 ) ) PUNCT iajs-312 55 23 technique technique NOUN iajs-312 55 24 using use VERB iajs-312 55 25 the the DET iajs-312 55 26 manufacturer manufacturer NOUN iajs-312 55 27 instruction instruction NOUN iajs-312 55 28 as as SCONJ iajs-312 55 29 supplied supply VERB iajs-312 55 30 with with ADP iajs-312 55 31 kit kit NOUN iajs-312 55 32 from from ADP iajs-312 55 33 cusabio cusabio PROPN iajs-312 55 34 , , PUNCT iajs-312 55 35 china china PROPN iajs-312 55 36 . . PUNCT iajs-312 56 1 igg igg PROPN iajs-312 56 2 determination determination PROPN iajs-312 56 3 igg igg PROPN iajs-312 56 4 was be AUX iajs-312 56 5 determined determine VERB iajs-312 56 6 acoording acoorde VERB iajs-312 56 7 to to ADP iajs-312 56 8 the the DET iajs-312 56 9 manufacturer manufacturer NOUN iajs-312 56 10 instruction instruction NOUN iajs-312 56 11 as as SCONJ iajs-312 56 12 supplied supply VERB iajs-312 56 13 with with ADP iajs-312 56 14 kit kit NOUN iajs-312 56 15 from from ADP iajs-312 56 16 bussero bussero PROPN iajs-312 56 17 ( ( PUNCT iajs-312 56 18 mi mi PROPN iajs-312 56 19 ) ) PUNCT iajs-312 56 20 italy italy PROPN iajs-312 56 21 . . PUNCT iajs-312 56 22 . . PUNCT iajs-312 57 1 statistical statistical ADJ iajs-312 57 2 analysis analysis NOUN iajs-312 57 3 results result NOUN iajs-312 57 4 were be AUX iajs-312 57 5 expressed express VERB iajs-312 57 6 as as ADP iajs-312 57 7 mean± mean± PROPN iajs-312 57 8 sem sem PROPN iajs-312 57 9 . . PUNCT iajs-312 58 1 student student NOUN iajs-312 58 2 - - PUNCT iajs-312 58 3 test test NOUN iajs-312 58 4 was be AUX iajs-312 58 5 used use VERB iajs-312 58 6 to to PART iajs-312 58 7 show show VERB iajs-312 58 8 the the DET iajs-312 58 9 difference difference NOUN iajs-312 58 10 between between ADP iajs-312 58 11 groups group NOUN iajs-312 58 12 variation variation NOUN iajs-312 58 13 which which PRON iajs-312 58 14 considered consider VERB iajs-312 58 15 significant significant ADJ iajs-312 58 16 when when SCONJ iajs-312 58 17 p- p- NOUN iajs-312 58 18     SPACE iajs-312 58 19 values value NOUN iajs-312 58 20 are be AUX iajs-312 58 21 ≤ ≤ NOUN iajs-312 58 22 0.05 0.05 NUM iajs-312 58 23 . . PUNCT iajs-312 59 1 the the DET iajs-312 59 2 correlation correlation NOUN iajs-312 59 3 coefficient coefficient NOUN iajs-312 59 4 ( ( PUNCT iajs-312 59 5 r r NOUN iajs-312 59 6 ) ) PUNCT iajs-312 59 7 test test NOUN iajs-312 59 8 is be AUX iajs-312 59 9 used use VERB iajs-312 59 10 to to PART iajs-312 59 11 describe describe VERB iajs-312 59 12 the the DET iajs-312 59 13     SPACE iajs-312 59 14 association association NOUN iajs-312 59 15 between between ADP iajs-312 59 16 the the DET iajs-312 59 17 different different ADJ iajs-312 59 18 studied studied ADJ iajs-312 59 19 parameters parameter NOUN iajs-312 59 20 . . PUNCT iajs-312 60 1 results result NOUN iajs-312 60 2 table table NOUN iajs-312 60 3 ( ( PUNCT iajs-312 60 4 1 1 X iajs-312 60 5 ) ) PUNCT iajs-312 60 6 showed show VERB iajs-312 60 7 the the DET iajs-312 60 8 levels level NOUN iajs-312 60 9 of of ADP iajs-312 60 10 sialic sialic ADJ iajs-312 60 11 acid acid NOUN iajs-312 60 12 , , PUNCT iajs-312 60 13 paraoxonase-1 paraoxonase-1 NUM iajs-312 60 14 and and CCONJ iajs-312 60 15 igg igg PROPN iajs-312 60 16 concentration concentration NOUN iajs-312 60 17 in in ADP iajs-312 60 18 sera sera NOUN iajs-312 60 19 of of ADP iajs-312 60 20 g1 g1 PROPN iajs-312 60 21 , , PUNCT iajs-312 60 22 g2 g2 PROPN iajs-312 60 23 , , PUNCT iajs-312 60 24 g3 g3 NOUN iajs-312 60 25 and and CCONJ iajs-312 60 26 g4 g4 NOUN iajs-312 60 27 for for ADP iajs-312 60 28 patients patient NOUN iajs-312 60 29 and and CCONJ iajs-312 60 30 control control VERB iajs-312 60 31 respectively respectively ADV iajs-312 60 32 . . PUNCT iajs-312 61 1 the the DET iajs-312 61 2 results result NOUN iajs-312 61 3 showed show VERB iajs-312 61 4 significant significant ADJ iajs-312 61 5 increase increase NOUN iajs-312 61 6 in in ADP iajs-312 61 7 levels level NOUN iajs-312 61 8 of of ADP iajs-312 61 9 sialic sialic ADJ iajs-312 61 10 acid acid NOUN iajs-312 61 11 in in ADP iajs-312 61 12 g2 g2 PROPN iajs-312 61 13 and and CCONJ iajs-312 61 14 g4 g4 NOUN iajs-312 61 15 comparing compare VERB iajs-312 61 16 to to ADP iajs-312 61 17 g1 g1 NOUN iajs-312 61 18 , , PUNCT iajs-312 61 19 while while SCONJ iajs-312 61 20 there there PRON iajs-312 61 21 is be VERB iajs-312 61 22 non non ADJ iajs-312 61 23 - - ADJ iajs-312 61 24 significant significant ADJ iajs-312 61 25 increase increase NOUN iajs-312 61 26 in in ADP iajs-312 61 27 g3 g3 NOUN iajs-312 61 28 comparing compare VERB iajs-312 61 29 to to ADP iajs-312 61 30 g1 g1 PROPN iajs-312 61 31 . . PUNCT iajs-312 62 1 also also ADV iajs-312 62 2 , , PUNCT iajs-312 62 3 there there PRON iajs-312 62 4 is be VERB iajs-312 62 5 significant significant ADJ iajs-312 62 6 decrease decrease NOUN iajs-312 62 7 in in ADP iajs-312 62 8 pon-1levels pon-1level NOUN iajs-312 62 9 in in ADP iajs-312 62 10 g2 g2 PROPN iajs-312 62 11 comparing compare VERB iajs-312 62 12 to to ADP iajs-312 62 13 g1,while g1,while NOUN iajs-312 62 14 there there PRON iajs-312 62 15 is be VERB iajs-312 62 16 non non ADJ iajs-312 62 17 - - ADJ iajs-312 62 18 significant significant ADJ iajs-312 62 19 decrease decrease NOUN iajs-312 62 20 in in ADP iajs-312 62 21 pon-1 pon-1 PUNCT iajs-312 62 22 levels level NOUN iajs-312 62 23 in in ADP iajs-312 62 24 g3 g3 NOUN iajs-312 62 25 and and CCONJ iajs-312 62 26 g4 g4 NOUN iajs-312 62 27 comparing compare VERB iajs-312 62 28 to to ADP iajs-312 62 29 g1 g1 PROPN iajs-312 62 30 . . PUNCT iajs-312 63 1 the the DET iajs-312 63 2 results result NOUN iajs-312 63 3 also also ADV iajs-312 63 4 showed show VERB iajs-312 63 5 non non ADJ iajs-312 63 6 - - ADJ iajs-312 63 7 significant significant ADJ iajs-312 63 8 decrease decrease NOUN iajs-312 63 9 in in ADP iajs-312 63 10 g2 g2 PROPN iajs-312 63 11 comparing compare VERB iajs-312 63 12 to to ADP iajs-312 63 13 g1and g1and PROPN iajs-312 63 14 non non ADJ iajs-312 63 15 - - ADJ iajs-312 63 16 significant significant ADJ iajs-312 63 17 in in ADP iajs-312 63 18 g3comparing g3compare VERB iajs-312 63 19 to to ADP iajs-312 63 20 g1 g1 NOUN iajs-312 63 21 , , PUNCT iajs-312 63 22 while while SCONJ iajs-312 63 23 there there PRON iajs-312 63 24 is be VERB iajs-312 63 25 increase increase NOUN iajs-312 63 26 in in ADP iajs-312 63 27 g4 g4 NOUN iajs-312 63 28 comparing compare VERB iajs-312 63 29 to to AUX iajs-312 63 30 g1 g1 VERB iajs-312 63 31 . . PUNCT iajs-312 64 1 table table NOUN iajs-312 64 2 ( ( PUNCT iajs-312 64 3 2 2 X iajs-312 64 4 ) ) PUNCT iajs-312 64 5 showed show VERB iajs-312 64 6 the the DET iajs-312 64 7 correlation correlation NOUN iajs-312 64 8 relation relation NOUN iajs-312 64 9 of of ADP iajs-312 64 10 sialic sialic ADJ iajs-312 64 11 acid acid NOUN iajs-312 64 12 , , PUNCT iajs-312 64 13 pon-1and pon-1and NOUN iajs-312 64 14 igg igg PROPN iajs-312 64 15 for for ADP iajs-312 64 16 patients patient NOUN iajs-312 64 17 with with ADP iajs-312 64 18 duration duration NOUN iajs-312 64 19 of of ADP iajs-312 64 20 disease disease NOUN iajs-312 64 21 . . PUNCT iajs-312 65 1 the the DET iajs-312 65 2 results result NOUN iajs-312 65 3 showed show VERB iajs-312 65 4 positive positive ADJ iajs-312 65 5 correlation correlation NOUN iajs-312 65 6 in in ADP iajs-312 65 7 g2 g2 PROPN iajs-312 65 8 and and CCONJ iajs-312 65 9 g4 g4 NOUN iajs-312 65 10 for for ADP iajs-312 65 11 sialic sialic ADJ iajs-312 65 12 acid acid NOUN iajs-312 65 13 with with ADP iajs-312 65 14 duration duration NOUN iajs-312 65 15 ( ( PUNCT iajs-312 65 16 r r NOUN iajs-312 65 17 = = NOUN iajs-312 65 18 0.158 0.158 NUM iajs-312 65 19 , , PUNCT iajs-312 65 20 r r NOUN iajs-312 65 21 = = NOUN iajs-312 65 22 0.019 0.019 NUM iajs-312 65 23 ) ) PUNCT iajs-312 65 24 , , PUNCT iajs-312 65 25 while while SCONJ iajs-312 65 26 negative negative ADJ iajs-312 65 27 correlation correlation NOUN iajs-312 65 28 was be AUX iajs-312 65 29 found find VERB iajs-312 65 30 between between ADP iajs-312 65 31 g3 g3 NOUN iajs-312 65 32 and and CCONJ iajs-312 65 33 duration duration NOUN iajs-312 65 34 ( ( PUNCT iajs-312 65 35 figure figure NOUN iajs-312 65 36 1 1 NUM iajs-312 65 37 ) ) PUNCT iajs-312 65 38 . . PUNCT iajs-312 66 1 also also ADV iajs-312 66 2 , , PUNCT iajs-312 66 3 the the DET iajs-312 66 4 results result NOUN iajs-312 66 5 showed show VERB iajs-312 66 6 positive positive ADJ iajs-312 66 7 correlation correlation NOUN iajs-312 66 8 in in ADP iajs-312 66 9 g2 g2 PROPN iajs-312 66 10 and and CCONJ iajs-312 66 11 g4 g4 NOUN iajs-312 66 12 ( ( PUNCT iajs-312 66 13 r r NOUN iajs-312 66 14 = = SYM iajs-312 66 15 0.123 0.123 NUM iajs-312 66 16 , , PUNCT iajs-312 66 17 r r NOUN iajs-312 66 18 = = SYM iajs-312 66 19 0.071 0.071 NUM iajs-312 66 20 ) ) PUNCT iajs-312 66 21 for for ADP iajs-312 66 22 pon-1 pon-1 X iajs-312 66 23 with with ADP iajs-312 66 24 duration duration NOUN iajs-312 66 25 , , PUNCT iajs-312 66 26 while while SCONJ iajs-312 66 27 negative negative ADJ iajs-312 66 28 correlation correlation NOUN iajs-312 66 29 was be AUX iajs-312 66 30 found find VERB iajs-312 66 31 in in ADP iajs-312 66 32 g3 g3 NOUN iajs-312 66 33 for for ADP iajs-312 66 34 pon-1 pon-1 PUNCT iajs-312 66 35 with with ADP iajs-312 66 36 duration duration NOUN iajs-312 66 37 ( ( PUNCT iajs-312 66 38 figure figure NOUN iajs-312 66 39 2 2 NUM iajs-312 66 40 ) ) PUNCT iajs-312 66 41 . . PUNCT iajs-312 67 1 also also ADV iajs-312 67 2 , , PUNCT iajs-312 67 3 the the DET iajs-312 67 4 results result NOUN iajs-312 67 5 showed show VERB iajs-312 67 6 negative negative ADJ iajs-312 67 7 correlation correlation NOUN iajs-312 67 8 in in ADP iajs-312 67 9 g1,g3 g1,g3 PROPN iajs-312 67 10 and and CCONJ iajs-312 67 11 g4 g4 NOUN iajs-312 67 12 in in ADP iajs-312 67 13 patients patient NOUN iajs-312 67 14 groupswithduration(figure3 groupswithduration(figure3 ADJ iajs-312 67 15 ) ) PUNCT iajs-312 67 16 . . PUNCT iajs-312 68 1 473 473 NUM iajs-312 69 1 | | ADV iajs-312 69 2 chemistry chemistry NOUN iajs-312 69 3 2014 2014 NUM iajs-312 69 4 ) ) PUNCT iajs-312 69 5 عام عام ADP iajs-312 69 6 3(العدد 3(العدد NUM iajs-312 69 7 27المجلد 27المجلد NUM iajs-312 69 8 مجلة مجلة VERB iajs-312 69 9 إبن إبن NOUN iajs-312 69 10 الھيثم الھيثم NOUN iajs-312 69 11 للعلوم للعلوم NOUN iajs-312 69 12 الصرفة الصرفة NOUN iajs-312 70 1 و و PRON iajs-312 70 2 التطبيقية التطبيقية ADJ iajs-312 70 3 ibn ibn PROPN iajs-312 70 4 al al PROPN iajs-312 70 5 - - PUNCT iajs-312 70 6 haitham haitham PROPN iajs-312 70 7 jour jour X iajs-312 70 8 . . PROPN iajs-312 70 9 for for ADP iajs-312 70 10 pure pure ADJ iajs-312 70 11 & & CCONJ iajs-312 70 12 appl appl PROPN iajs-312 70 13 . . PUNCT iajs-312 71 1 sci sci PROPN iajs-312 71 2 . . PUNCT iajs-312 71 3 vol vol NOUN iajs-312 71 4 . . PROPN iajs-312 72 1 27 27 NUM iajs-312 72 2 ( ( PUNCT iajs-312 72 3 3 3 NUM iajs-312 72 4 ) ) PUNCT iajs-312 72 5 2014 2014 NUM iajs-312 72 6 discussion discussion NOUN iajs-312 72 7 the the DET iajs-312 72 8 result result NOUN iajs-312 72 9 in in ADP iajs-312 72 10 the the DET iajs-312 72 11 present present ADJ iajs-312 72 12 study study NOUN iajs-312 72 13 showed show VERB iajs-312 72 14 that that SCONJ iajs-312 72 15 the the DET iajs-312 72 16 serum serum NOUN iajs-312 72 17 level level NOUN iajs-312 72 18 of of ADP iajs-312 72 19 sialic sialic ADJ iajs-312 72 20 acid acid NOUN iajs-312 72 21 was be AUX iajs-312 72 22 higher high ADJ iajs-312 72 23 in in ADP iajs-312 72 24 patients patient NOUN iajs-312 72 25 with with ADP iajs-312 72 26 pcos pcos PROPN iajs-312 72 27 . . PUNCT iajs-312 73 1 serum serum PROPN iajs-312 73 2 sa sa PROPN iajs-312 73 3 have have AUX iajs-312 73 4 been be AUX iajs-312 73 5 reported report VERB iajs-312 73 6 to to PART iajs-312 73 7 be be AUX iajs-312 73 8 risk risk NOUN iajs-312 73 9 factor factor NOUN iajs-312 73 10 for for ADP iajs-312 73 11 cardiovascular cardiovascular ADJ iajs-312 73 12 disease disease NOUN iajs-312 73 13 and and CCONJ iajs-312 73 14 found find VERB iajs-312 73 15 strong strong ADJ iajs-312 73 16     SPACE iajs-312 73 17 expression expression NOUN iajs-312 73 18 of of ADP iajs-312 73 19 siglec-11 siglec-11 PROPN iajs-312 73 20 in in ADP iajs-312 73 21 human human ADJ iajs-312 73 22 pcos pcos PROPN iajs-312 73 23 ovaries ovary NOUN iajs-312 73 24 . . PUNCT iajs-312 74 1 interestingly interestingly ADV iajs-312 74 2     SPACE iajs-312 74 3 somewhat somewhat ADV iajs-312 74 4 increased increase VERB iajs-312 74 5 expression expression NOUN iajs-312 74 6 of of ADP iajs-312 74 7 siglec-11 siglec-11 PROPN iajs-312 74 8 was be AUX iajs-312 74 9 also also ADV iajs-312 74 10     SPACE iajs-312 74 11 observed observe VERB iajs-312 74 12 in in ADP iajs-312 74 13 post post ADJ iajs-312 74 14 - - ADJ iajs-312 74 15 menopausal menopausal ADJ iajs-312 74 16 ovaries ovary NOUN iajs-312 74 17 compared compare VERB iajs-312 74 18 with with ADP iajs-312 74 19 premenopausal premenopausal NOUN iajs-312 74 20     SPACE iajs-312 74 21 ones one NOUN iajs-312 74 22 [ [ X iajs-312 74 23 20 20 NUM iajs-312 74 24 ] ] PUNCT iajs-312 74 25 . . PUNCT iajs-312 75 1 seventy seventy NUM iajs-312 75 2 five five NUM iajs-312 75 3 women woman NOUN iajs-312 75 4 with with ADP iajs-312 75 5 pcos pcos PROPN iajs-312 75 6 and and CCONJ iajs-312 75 7 25 25 NUM iajs-312 75 8 controls control NOUN iajs-312 75 9 were be AUX iajs-312 75 10 included include VERB iajs-312 75 11 and and CCONJ iajs-312 75 12 it it PRON iajs-312 75 13 was be AUX iajs-312 75 14 found find VERB iajs-312 75 15 that that SCONJ iajs-312 75 16 sa sa PROPN iajs-312 75 17 levels level NOUN iajs-312 75 18 were be AUX iajs-312 75 19 similar similar ADJ iajs-312 75 20 in in ADP iajs-312 75 21 g2 g2 PROPN iajs-312 75 22 and and CCONJ iajs-312 75 23 g3 g3 PROPN iajs-312 75 24 ( ( PUNCT iajs-312 75 25 10.5±2.011 10.5±2.011 NUM iajs-312 75 26 ) ) PUNCT iajs-312 75 27 and and CCONJ iajs-312 75 28 ( ( PUNCT iajs-312 75 29 10.25±2.051 10.25±2.051 NUM iajs-312 75 30 ) ) PUNCT iajs-312 75 31 and and CCONJ iajs-312 75 32 level level NOUN iajs-312 75 33 of of ADP iajs-312 75 34 sa sa PROPN iajs-312 75 35 in in ADP iajs-312 75 36 g3 g3 PROPN iajs-312 75 37 elevated elevate VERB iajs-312 75 38 ( ( PUNCT iajs-312 75 39 13.66±2.73).this 13.66±2.73).this PRON iajs-312 75 40 result result NOUN iajs-312 75 41 is be AUX iajs-312 75 42 incontrast incontrast ADJ iajs-312 75 43 with with ADP iajs-312 75 44 ali ali PROPN iajs-312 75 45 ( ( PUNCT iajs-312 75 46 2012 2012 NUM iajs-312 75 47 ) ) PUNCT iajs-312 75 48 in in ADP iajs-312 75 49 his his PRON iajs-312 75 50 study study NOUN iajs-312 75 51 , , PUNCT iajs-312 75 52 ali ali PROPN iajs-312 75 53 found find VERB iajs-312 75 54 level level NOUN iajs-312 75 55 of of ADP iajs-312 75 56 sialic sialic ADJ iajs-312 75 57 acid acid NOUN iajs-312 75 58 did do AUX iajs-312 75 59 not not PART iajs-312 75 60 differ differ VERB iajs-312 75 61 [ [ X iajs-312 75 62 10 10 NUM iajs-312 75 63 ] ] PUNCT iajs-312 75 64 . . PUNCT iajs-312 76 1 previous previous ADJ iajs-312 76 2 study study NOUN iajs-312 76 3 showed show VERB iajs-312 76 4 that that SCONJ iajs-312 76 5 sialic sialic ADJ iajs-312 76 6 acid acid NOUN iajs-312 76 7 levels level NOUN iajs-312 76 8 are be AUX iajs-312 76 9 lower low ADJ iajs-312 76 10 , , PUNCT iajs-312 76 11 when when SCONJ iajs-312 76 12 metformin metformin NOUN iajs-312 76 13 as as ADP iajs-312 76 14 a a DET iajs-312 76 15 drug drug NOUN iajs-312 76 16 [ [ X iajs-312 76 17 5 5 NUM iajs-312 76 18 ] ] PUNCT iajs-312 76 19 , , PUNCT iajs-312 76 20 while while SCONJ iajs-312 76 21 other other ADJ iajs-312 76 22 study study NOUN iajs-312 76 23 showed show VERB iajs-312 76 24 none none NOUN iajs-312 76 25 of of ADP iajs-312 76 26 the the DET iajs-312 76 27 novel novel ADJ iajs-312 76 28 surrogate surrogate ADJ iajs-312 76 29 biochemical biochemical ADJ iajs-312 76 30 markers marker NOUN iajs-312 76 31 of of ADP iajs-312 76 32 cardiovascular cardiovascular ADJ iajs-312 76 33 risk risk NOUN iajs-312 76 34 was be AUX iajs-312 76 35 raised raise VERB iajs-312 76 36 in in ADP iajs-312 76 37 our our PRON iajs-312 76 38 women woman NOUN iajs-312 76 39 with with ADP iajs-312 76 40 pcos pcos PROPN iajs-312 76 41 [ [ X iajs-312 76 42 21 21 NUM iajs-312 76 43 ] ] PUNCT iajs-312 76 44 . . PUNCT iajs-312 77 1 women woman NOUN iajs-312 77 2 with with ADP iajs-312 77 3 pcos pcos PROPN iajs-312 77 4 cluster cluster NOUN iajs-312 77 5 risk risk NOUN iajs-312 77 6 factors factor NOUN iajs-312 77 7 associated associate VERB iajs-312 77 8 with with ADP iajs-312 77 9 risk risk NOUN iajs-312 77 10 of of ADP iajs-312 77 11 atherosclerosis atherosclerosis NOUN iajs-312 77 12 , , PUNCT iajs-312 77 13 these these DET iajs-312 77 14 risk risk NOUN iajs-312 77 15 factors factor NOUN iajs-312 77 16 include include VERB iajs-312 77 17 dyslipidemia dyslipidemia NOUN iajs-312 77 18 and and CCONJ iajs-312 77 19 oxidative oxidative ADJ iajs-312 77 20 stress stress NOUN iajs-312 77 21 [ [ X iajs-312 77 22 22 22 NUM iajs-312 77 23 ] ] PUNCT iajs-312 77 24 . . PUNCT iajs-312 78 1 in in ADP iajs-312 78 2 this this DET iajs-312 78 3 study study NOUN iajs-312 78 4 , , PUNCT iajs-312 78 5 serum serum PROPN iajs-312 78 6 pon1 pon1 NOUN iajs-312 78 7 activity activity NOUN iajs-312 78 8 was be AUX iajs-312 78 9 found find VERB iajs-312 78 10 that that SCONJ iajs-312 78 11 levels level NOUN iajs-312 78 12 in in ADP iajs-312 78 13 g2 g2 PROPN iajs-312 78 14 were be AUX iajs-312 78 15 lower low ADJ iajs-312 78 16 ( ( PUNCT iajs-312 78 17 174.7± 174.7± NUM iajs-312 78 18 34.95 34.95 NUM iajs-312 78 19 ) ) PUNCT iajs-312 78 20 compared compare VERB iajs-312 78 21 with with ADP iajs-312 78 22 levels level NOUN iajs-312 78 23 in in ADP iajs-312 78 24 g3 g3 NOUN iajs-312 78 25 and and CCONJ iajs-312 78 26 g4 g4 NOUN iajs-312 78 27 was be AUX iajs-312 78 28 similar similar ADJ iajs-312 78 29 ( ( PUNCT iajs-312 78 30 321.5± 321.5± NOUN iajs-312 78 31 64.31 64.31 NUM iajs-312 78 32 ) ) PUNCT iajs-312 78 33 and and CCONJ iajs-312 78 34 324.2±64.85 324.2±64.85 NUM iajs-312 78 35 ) ) PUNCT iajs-312 78 36 respectively respectively ADV iajs-312 78 37 .also .also PUNCT iajs-312 78 38 in in ADP iajs-312 78 39 this this DET iajs-312 78 40 study study NOUN iajs-312 78 41 , , PUNCT iajs-312 78 42 serum serum PROPN iajs-312 78 43 pon1activity pon1activity PROPN iajs-312 78 44 was be AUX iajs-312 78 45 significantly significantly ADV iajs-312 78 46 lower low ADJ iajs-312 78 47 in in ADP iajs-312 78 48 patients patient NOUN iajs-312 78 49 with with ADP iajs-312 78 50 pcos pco NOUN iajs-312 78 51 than than ADP iajs-312 78 52 healthy healthy ADJ iajs-312 78 53 controls control NOUN iajs-312 78 54 . . PUNCT iajs-312 79 1 recent recent ADJ iajs-312 79 2 literature literature NOUN iajs-312 79 3 search search NOUN iajs-312 79 4 revealed reveal VERB iajs-312 79 5 there there PRON iajs-312 79 6 are be VERB iajs-312 79 7 few few ADJ iajs-312 79 8 studies study NOUN iajs-312 79 9 about about ADP iajs-312 79 10 pon1 pon1 NOUN iajs-312 79 11 activity activity NOUN iajs-312 79 12 in in ADP iajs-312 79 13 pcos pcos NOUN iajs-312 79 14 patients patient NOUN iajs-312 79 15 . . PUNCT iajs-312 80 1 in in ADP iajs-312 80 2 addition addition NOUN iajs-312 80 3 , , PUNCT iajs-312 80 4 it it PRON iajs-312 80 5 suggested suggest VERB iajs-312 80 6 that that SCONJ iajs-312 80 7 decreased decrease VERB iajs-312 80 8 antioxidant antioxidant ADJ iajs-312 80 9 pon1 pon1 NOUN iajs-312 80 10 activity activity NOUN iajs-312 80 11 might might AUX iajs-312 80 12 contribute contribute VERB iajs-312 80 13 to to ADP iajs-312 80 14 increased increase VERB iajs-312 80 15 susceptibility susceptibility NOUN iajs-312 80 16 for for ADP iajs-312 80 17 the the DET iajs-312 80 18 development development NOUN iajs-312 80 19 of of ADP iajs-312 80 20 atherosclerosis atherosclerosis NOUN iajs-312 80 21 risk risk NOUN iajs-312 80 22 in in ADP iajs-312 80 23 women woman NOUN iajs-312 80 24 with with ADP iajs-312 80 25 pcos pcos PROPN iajs-312 80 26 [ [ X iajs-312 80 27 23 23 NUM iajs-312 80 28 ] ] PUNCT iajs-312 80 29 . . PUNCT iajs-312 80 30 . . PUNCT iajs-312 81 1 the the DET iajs-312 81 2 results result NOUN iajs-312 81 3 of of ADP iajs-312 81 4 the the DET iajs-312 81 5 current current ADJ iajs-312 81 6 study study NOUN iajs-312 81 7 indicate indicate VERB iajs-312 81 8 that that DET iajs-312 81 9 pon1 pon1 NOUN iajs-312 81 10 activity activity NOUN iajs-312 81 11 was be AUX iajs-312 81 12 significantly significantly ADV iajs-312 81 13 decreased decrease VERB iajs-312 81 14 in in ADP iajs-312 81 15 patients patient NOUN iajs-312 81 16 with with ADP iajs-312 81 17 pcos pco NOUN iajs-312 81 18 when when SCONJ iajs-312 81 19 compared compare VERB iajs-312 81 20 with with ADP iajs-312 81 21 healthy healthy ADJ iajs-312 81 22 controls.in controls.in PROPN iajs-312 81 23 previous previous ADJ iajs-312 81 24 study study NOUN iajs-312 81 25 , , PUNCT iajs-312 81 26 reduced reduce VERB iajs-312 81 27 serum serum NOUN iajs-312 81 28 pon1 pon1 NOUN iajs-312 81 29 activity activity NOUN iajs-312 81 30 has have AUX iajs-312 81 31 been be AUX iajs-312 81 32 reported report VERB iajs-312 81 33 to to PART iajs-312 81 34 be be AUX iajs-312 81 35 associated associate VERB iajs-312 81 36 with with ADP iajs-312 81 37 insulin insulin NOUN iajs-312 81 38 resistance resistance NOUN iajs-312 82 1 [ [ X iajs-312 82 2 24 24 NUM iajs-312 82 3 ] ] PUNCT iajs-312 82 4 . . PUNCT iajs-312 83 1 also also ADV iajs-312 83 2 lower low ADJ iajs-312 83 3 serum serum NOUN iajs-312 83 4 pon1 pon1 NOUN iajs-312 83 5 activity activity NOUN iajs-312 83 6 has have AUX iajs-312 83 7 been be AUX iajs-312 83 8 associated associate VERB iajs-312 83 9 with with ADP iajs-312 83 10 increased increase VERB iajs-312 83 11 susceptibility susceptibility NOUN iajs-312 83 12 to to ADP iajs-312 83 13 atherosclerosis atherosclerosis NOUN iajs-312 83 14 , , PUNCT iajs-312 83 15 neuro neuro NOUN iajs-312 83 16 pathy pathy NOUN iajs-312 83 17 and and CCONJ iajs-312 83 18 other other ADJ iajs-312 83 19 complications complication NOUN iajs-312 83 20 in in ADP iajs-312 83 21 diabetic diabetic ADJ iajs-312 83 22 population population NOUN iajs-312 83 23 compared compare VERB iajs-312 83 24 with with ADP iajs-312 83 25 healthy healthy ADJ iajs-312 83 26 controls control NOUN iajs-312 83 27 [ [ X iajs-312 83 28 25 25 NUM iajs-312 83 29 ] ] PUNCT iajs-312 83 30 . . PUNCT iajs-312 83 31     SPACE iajs-312 84 1 igg igg PROPN iajs-312 84 2 is be AUX iajs-312 84 3 the the DET iajs-312 84 4 most most ADV iajs-312 84 5 abundant abundant ADJ iajs-312 84 6 immunoglobulin immunoglobulin NOUN iajs-312 84 7 , , PUNCT iajs-312 84 8 accounting account VERB iajs-312 84 9 for for ADP iajs-312 84 10 approximately approximately ADV iajs-312 84 11 75 75 NUM iajs-312 84 12 % % NOUN iajs-312 84 13 of of ADP iajs-312 84 14 the the DET iajs-312 84 15 total total ADJ iajs-312 84 16 amount amount NOUN iajs-312 84 17 of of ADP iajs-312 84 18 serum serum NOUN iajs-312 84 19 immunoglobulin immunoglobulin NOUN iajs-312 84 20 , , PUNCT iajs-312 84 21 and and CCONJ iajs-312 84 22 the the DET iajs-312 84 23 major major ADJ iajs-312 84 24 immunoglobulin immunoglobulin NOUN iajs-312 84 25 of of ADP iajs-312 84 26 secondary secondary ADJ iajs-312 84 27 immune immune ADJ iajs-312 84 28 response response NOUN iajs-312 84 29 [ [ X iajs-312 84 30 26 26 NUM iajs-312 84 31 ] ] PUNCT iajs-312 84 32 . . PUNCT iajs-312 85 1 so so ADV iajs-312 85 2 as as SCONJ iajs-312 85 3 recent recent ADJ iajs-312 85 4 study study NOUN iajs-312 85 5 have have AUX iajs-312 85 6 shown show VERB iajs-312 85 7 that that SCONJ iajs-312 85 8 the the DET iajs-312 85 9 minor minor ADJ iajs-312 85 10 subset subset NOUN iajs-312 85 11 of of ADP iajs-312 85 12 circulating circulate VERB iajs-312 85 13 igg igg PROPN iajs-312 85 14 that that PRON iajs-312 85 15 have have VERB iajs-312 85 16 α-2 α-2 NOUN iajs-312 85 17 - - SYM iajs-312 85 18 6 6 NUM iajs-312 85 19 linked link VERB iajs-312 85 20 sias sia NOUN iajs-312 85 21 terminating terminate VERB iajs-312 85 22 its its PRON iajs-312 85 23 n n CCONJ iajs-312 85 24 - - PUNCT iajs-312 85 25 glycan glycan NOUN iajs-312 85 26 has have VERB iajs-312 85 27 an an DET iajs-312 85 28 inhibitory inhibitory ADJ iajs-312 85 29 potential potential NOUN iajs-312 85 30 , , PUNCT iajs-312 85 31 working work VERB iajs-312 85 32 through through ADP iajs-312 85 33 the the DET iajs-312 85 34 human human ADJ iajs-312 85 35 dc dc PROPN iajs-312 85 36 - - PUNCT iajs-312 85 37 s1gn s1gn NUM iajs-312 85 38 receptor receptor NOUN iajs-312 85 39 on on ADP iajs-312 85 40 regulatory regulatory ADJ iajs-312 85 41 macrophages macrophage NOUN iajs-312 85 42 to to PART iajs-312 85 43 up up VERB iajs-312 85 44 regulates regulate VERB iajs-312 85 45 fcr fcr PROPN iajs-312 85 46 γ γ PROPN iajs-312 85 47 ii ii PROPN iajs-312 85 48 b b PROPN iajs-312 85 49 on on ADP iajs-312 85 50 other other ADJ iajs-312 85 51 macrophages macrophage NOUN iajs-312 85 52 , , PUNCT iajs-312 85 53 and and CCONJ iajs-312 85 54 thereby thereby ADV iajs-312 85 55 dampen dampen VERB iajs-312 85 56 [ [ X iajs-312 85 57 27 27 NUM iajs-312 85 58 ] ] PUNCT iajs-312 85 59 . . PUNCT iajs-312 86 1 this this PRON iajs-312 86 2 is be AUX iajs-312 86 3 also also ADV iajs-312 86 4 suggested suggest VERB iajs-312 86 5 to to PART iajs-312 86 6 be be AUX iajs-312 86 7 the the DET iajs-312 86 8 mechanism mechanism NOUN iajs-312 86 9 of of ADP iajs-312 86 10 action action NOUN iajs-312 86 11 of of ADP iajs-312 86 12 intravenous intravenous ADJ iajs-312 86 13 pooled pool VERB iajs-312 86 14 human human PROPN iajs-312 86 15 igg igg PROPN iajs-312 86 16 ( ( PUNCT iajs-312 86 17 ivig ivig PROPN iajs-312 86 18 ) ) PUNCT iajs-312 86 19 that that PRON iajs-312 86 20 is be AUX iajs-312 86 21 used use VERB iajs-312 86 22 for for ADP iajs-312 86 23 immune immune ADJ iajs-312 86 24 suppression suppression NOUN iajs-312 86 25 in in ADP iajs-312 86 26 the the DET iajs-312 86 27 clinical clinical NOUN iajs-312 86 28 ; ; PUNCT iajs-312 86 29 the the DET iajs-312 86 30 worth worth NOUN iajs-312 86 31 mostly mostly ADV iajs-312 86 32 involves involve VERB iajs-312 86 33 a a DET iajs-312 86 34 single single ADJ iajs-312 86 35 model model NOUN iajs-312 86 36 system system NOUN iajs-312 86 37 for for ADP iajs-312 86 38 autoimmune autoimmune ADJ iajs-312 86 39 disease disease NOUN iajs-312 86 40 ( ( PUNCT iajs-312 86 41 anthony anthony PROPN iajs-312 86 42 et et NOUN iajs-312 86 43 al.2011 al.2011 PROPN iajs-312 86 44 ) ) PUNCT iajs-312 86 45 . . PUNCT iajs-312 87 1 the the DET iajs-312 87 2 result result NOUN iajs-312 87 3 in in ADP iajs-312 87 4 the the DET iajs-312 87 5 present present ADJ iajs-312 87 6 study study NOUN iajs-312 87 7 showed show VERB iajs-312 87 8 that that SCONJ iajs-312 87 9 the the DET iajs-312 87 10 serum serum NOUN iajs-312 87 11 level level NOUN iajs-312 87 12 of of ADP iajs-312 87 13 igg igg PROPN iajs-312 87 14 was be AUX iajs-312 87 15 highly highly ADV iajs-312 87 16 significant significant ADJ iajs-312 87 17 increased increase VERB iajs-312 87 18 ( ( PUNCT iajs-312 87 19 p<0.001 p<0.001 PROPN iajs-312 87 20 ) ) PUNCT iajs-312 87 21 g2 g2 PROPN iajs-312 87 22 ( ( PUNCT iajs-312 87 23 493.08± 493.08± NUM iajs-312 87 24 98.61)mg 98.61)mg NUM iajs-312 87 25 / / SYM iajs-312 87 26 di di NOUN iajs-312 87 27 compared compare VERB iajs-312 87 28 to to PART iajs-312 87 29 control control VERB iajs-312 87 30 healthy healthy ADJ iajs-312 87 31 group group NOUN iajs-312 87 32 and and CCONJ iajs-312 87 33 g3 g3 PROPN iajs-312 87 34 ( ( PUNCT iajs-312 87 35 513.93±102.7 513.93±102.7 NUM iajs-312 87 36 ) ) PUNCT iajs-312 87 37 and and CCONJ iajs-312 87 38 g4 g4 NOUN iajs-312 87 39 ( ( PUNCT iajs-312 87 40 590.4±241.5 590.4±241.5 NOUN iajs-312 87 41 ) ) PUNCT iajs-312 87 42 . . PUNCT iajs-312 88 1 while while SCONJ iajs-312 88 2 non non ADJ iajs-312 88 3 - - ADJ iajs-312 88 4 significant significant ADJ iajs-312 88 5 difference difference NOUN iajs-312 88 6 ( ( PUNCT iajs-312 88 7 p>0.05 p>0.05 NOUN iajs-312 88 8 ) ) PUNCT iajs-312 88 9 was be AUX iajs-312 88 10 noticed notice VERB iajs-312 88 11 among among ADP iajs-312 88 12 the the DET iajs-312 88 13 patient patient NOUN iajs-312 88 14 groups group NOUN iajs-312 88 15 .the .the DET iajs-312 88 16 conclusion conclusion NOUN iajs-312 88 17 could could AUX iajs-312 88 18 be be AUX iajs-312 88 19 drawn draw VERB iajs-312 88 20 from from ADP iajs-312 88 21 this this DET iajs-312 88 22 study study NOUN iajs-312 88 23 that that SCONJ iajs-312 88 24 the the DET iajs-312 88 25 levels level NOUN iajs-312 88 26 of of ADP iajs-312 88 27 sialic sialic ADJ iajs-312 88 28 acid acid NOUN iajs-312 88 29 and and CCONJ iajs-312 88 30 pon-1 pon-1 PUNCT iajs-312 88 31 can can AUX iajs-312 88 32 be be AUX iajs-312 88 33 useful useful ADJ iajs-312 88 34 in in SCONJ iajs-312 88 35 predicted predict VERB iajs-312 88 36 the the DET iajs-312 88 37 risk risk NOUN iajs-312 88 38 for for ADP iajs-312 88 39 heart heart NOUN iajs-312 88 40 disease disease NOUN iajs-312 88 41 and and CCONJ iajs-312 89 1 dm dm NOUN iajs-312 89 2 . . PROPN iajs-312 89 3 references reference NOUN iajs-312 89 4 1goodarzi 1goodarzi NUM iajs-312 89 5 , , PUNCT iajs-312 89 6 m.o m.o PROPN iajs-312 89 7 . . PROPN iajs-312 89 8 ; ; PUNCT iajs-312 89 9 dumesic dumesic ADJ iajs-312 89 10 , , PUNCT iajs-312 89 11 da da ADJ iajs-312 89 12 ; ; PUNCT iajs-312 89 13 chazenbalk chazenbalk ADJ iajs-312 89 14 , , PUNCT iajs-312 89 15 g. g. PROPN iajs-312 89 16 and and CCONJ iajs-312 89 17 azziz azziz PROPN iajs-312 89 18 , , PUNCT iajs-312 89 19 r.(2011).polycystic r.(2011).polycystic ADJ iajs-312 89 20 ovary ovary ADJ iajs-312 89 21 syndrome syndrome NOUN iajs-312 89 22 : : PUNCT iajs-312 89 23 etiology etiology NOUN iajs-312 89 24 , , PUNCT iajs-312 89 25 pathogenesis pathogenesis NOUN iajs-312 89 26 and and CCONJ iajs-312 89 27 diagnosis diagnosis NOUN iajs-312 89 28 . . PUNCT iajs-312 90 1 nat nat PROPN iajs-312 90 2 rev rev VERB iajs-312 90 3 endocrinol endocrinol PROPN iajs-312 90 4 .2011 .2011 PROPN iajs-312 90 5 apr;7(4):21931.doi:10.1038 apr;7(4):21931.doi:10.1038 PROPN iajs-312 90 6 / / SYM iajs-312 90 7 nrendo.2010.217.epub nrendo.2010.217.epub ADJ iajs-312 90 8 2011 2011 NUM iajs-312 90 9 jan jan PROPN iajs-312 90 10 25 25 NUM iajs-312 90 11 . . PUNCT iajs-312 91 1 [ [ X iajs-312 91 2 pubmed pubmed NOUN iajs-312 91 3 - - PUNCT iajs-312 91 4 indexed index VERB iajs-312 91 5 for for ADP iajs-312 91 6 medline medline NOUN iajs-312 91 7 ] ] PUNCT iajs-312 91 8 . . PUNCT iajs-312 92 1 2 2 NUM iajs-312 92 2 - - PUNCT iajs-312 92 3 dinka dinka PROPN iajs-312 92 4 pavičić pavičić PROPN iajs-312 92 5 baldani baldani PROPN iajs-312 92 6 ; ; PUNCT iajs-312 92 7 lana lana PROPN iajs-312 92 8 škrgatić škrgatić PROPN iajs-312 92 9 ; ; PUNCT iajs-312 92 10 zrinka zrinka PROPN iajs-312 92 11 bukvić bukvić PROPN iajs-312 92 12 mokos mokos PROPN iajs-312 92 13 and and CCONJ iajs-312 92 14 iva iva PROPN iajs-312 92 15 trgovčić.(2013 trgovčić.(2013 NOUN iajs-312 92 16 ) ) PUNCT iajs-312 92 17 . . PUNCT iajs-312 93 1 hyperandrogenemia hyperandrogenemia PROPN iajs-312 93 2 association association PROPN iajs-312 93 3 with with ADP iajs-312 93 4 acne acne NOUN iajs-312 93 5 and and CCONJ iajs-312 93 6 hirsutism hirsutism NOUN iajs-312 93 7 severity severity NOUN iajs-312 93 8 in in ADP iajs-312 93 9 croatian croatian ADJ iajs-312 93 10 women woman NOUN iajs-312 93 11 with with ADP iajs-312 93 12 polycystic polycystic ADJ iajs-312 93 13 ovary ovary ADJ iajs-312 93 14 syndrome syndrome NOUN iajs-312 93 15 . . PUNCT iajs-312 94 1 21 21 NUM iajs-312 94 2 , , PUNCT iajs-312 94 3 2 2 NUM iajs-312 94 4 . . PUNCT iajs-312 94 5                                                                                       SPACE iajs-312 94 6 3 3 NUM iajs-312 94 7 wild wild ADJ iajs-312 94 8 , , PUNCT iajs-312 94 9 r.a r.a PROPN iajs-312 94 10 . . PROPN iajs-312 94 11 ; ; PUNCT iajs-312 94 12 carmina carmina PROPN iajs-312 94 13 , , PUNCT iajs-312 94 14 e. e. PROPN iajs-312 94 15 ; ; PUNCT iajs-312 94 16 diamanti diamanti PROPN iajs-312 94 17 - - PUNCT iajs-312 94 18 kandarakis kandarakis PROPN iajs-312 94 19 . . PUNCT iajs-312 95 1 e. e. PROPN iajs-312 95 2 ; ; PUNCT iajs-312 95 3 dokras dokra NOUN iajs-312 95 4 . . PUNCT iajs-312 95 5 a. a. NOUN iajs-312 95 6 ; ; PUNCT iajs-312 95 7 escobar escobar NOUN iajs-312 95 8 - - PUNCT iajs-312 95 9 morreale morreale NOUN iajs-312 95 10 . . PUNCT iajs-312 96 1 h.f h.f PROPN iajs-312 96 2 . . PROPN iajs-312 96 3 ; ; PUNCT iajs-312 96 4 futterweit.w futterweit.w NUM iajs-312 96 5 ; ; PUNCT iajs-312 97 1 lobo lobo PROPN iajs-312 97 2 . . PUNCT iajs-312 97 3 r. r. PROPN iajs-312 97 4 ; ; PUNCT iajs-312 97 5 norman norman PROPN iajs-312 97 6 . . PUNCT iajs-312 98 1 r.j r.j PROPN iajs-312 98 2 . . PROPN iajs-312 98 3 ; ; PUNCT iajs-312 99 1 talbott talbott PROPN iajs-312 99 2 . . PUNCT iajs-312 100 1 e. e. PROPN iajs-312 100 2 and and CCONJ iajs-312 100 3 dumesic dumesic ADJ iajs-312 100 4 , , PUNCT iajs-312 100 5 d.a.(2010 d.a.(2010 PROPN iajs-312 100 6 ) ) PUNCT iajs-312 100 7 . . PUNCT iajs-312 101 1 assessment assessment NOUN iajs-312 101 2 of of ADP iajs-312 101 3 cardiovascular cardiovascular ADJ iajs-312 101 4 risk risk NOUN iajs-312 101 5 and and CCONJ iajs-312 101 6 prevention prevention NOUN iajs-312 101 7 of of ADP iajs-312 101 8 cardiovascular cardiovascular ADJ iajs-312 101 9 disease disease NOUN iajs-312 101 10 in in ADP iajs-312 101 11 women woman NOUN iajs-312 101 12 with with ADP iajs-312 101 13 the the DET iajs-312 101 14 polycystic polycystic ADJ iajs-312 101 15 474 474 NUM iajs-312 101 16 | | ADV iajs-312 101 17 chemistry chemistry NOUN iajs-312 101 18 2014 2014 NUM iajs-312 101 19 ) ) PUNCT iajs-312 101 20 عام عام ADP iajs-312 101 21 3(العدد 3(العدد NUM iajs-312 101 22 27المجلد 27المجلد NUM iajs-312 101 23 مجلة مجلة VERB iajs-312 101 24 إبن إبن NOUN iajs-312 101 25 الھيثم الھيثم NOUN iajs-312 101 26 للعلوم للعلوم NOUN iajs-312 101 27 الصرفة الصرفة NOUN iajs-312 102 1 و و PRON iajs-312 102 2 التطبيقية التطبيقية ADJ iajs-312 102 3 ibn ibn PROPN iajs-312 102 4 al al PROPN iajs-312 102 5 - - PUNCT iajs-312 102 6 haitham haitham PROPN iajs-312 102 7 jour jour X iajs-312 102 8 . . PROPN iajs-312 102 9 for for ADP iajs-312 102 10 pure pure ADJ iajs-312 102 11 & & CCONJ iajs-312 102 12 appl appl PROPN iajs-312 102 13 . . PUNCT iajs-312 103 1 sci sci PROPN iajs-312 103 2 . . PUNCT iajs-312 103 3 vol vol NOUN iajs-312 103 4 . . PROPN iajs-312 104 1 27 27 NUM iajs-312 104 2 ( ( PUNCT iajs-312 104 3 3 3 NUM iajs-312 104 4 ) ) PUNCT iajs-312 104 5 2014 2014 NUM iajs-312 104 6 ovary ovary ADJ iajs-312 104 7 syndrome syndrome NOUN iajs-312 104 8 : : PUNCT iajs-312 104 9 a a DET iajs-312 104 10 consensus consensus NOUN iajs-312 104 11 statement statement NOUN iajs-312 104 12 by by ADP iajs-312 104 13 the the DET iajs-312 104 14 androgen androgen NOUN iajs-312 104 15 excess excess ADJ iajs-312 104 16 and and CCONJ iajs-312 104 17 polycystic polycystic ADJ iajs-312 104 18 ovary ovary ADJ iajs-312 104 19 syndrome syndrome NOUN iajs-312 104 20 ( ( PUNCT iajs-312 104 21 ae ae PROPN iajs-312 104 22 - - PUNCT iajs-312 104 23 pcos pcos PROPN iajs-312 104 24 ) ) PUNCT iajs-312 104 25 society society NOUN iajs-312 104 26 . . PUNCT iajs-312 105 1 j j PROPN iajs-312 105 2 clin clin PROPN iajs-312 105 3 endocrinol endocrinol NOUN iajs-312 105 4 metab metab NOUN iajs-312 105 5 ; ; PUNCT iajs-312 105 6 95:2038–2049 95:2038–2049 NUM iajs-312 105 7 . . PUNCT iajs-312 105 8     SPACE iajs-312 105 9 . . PUNCT iajs-312 106 1 4 4 NUM iajs-312 106 2 - - PUNCT iajs-312 106 3 schauer schauer NOUN iajs-312 106 4 . . PUNCT iajs-312 107 1 r.(1985).sialic r.(1985).sialic ADJ iajs-312 107 2 acids acid NOUN iajs-312 107 3 and and CCONJ iajs-312 107 4 their their PRON iajs-312 107 5 role role NOUN iajs-312 107 6 as as ADP iajs-312 107 7 biological biological ADJ iajs-312 107 8 markers.trends markers.trend NOUN iajs-312 107 9 biochem biochem NOUN iajs-312 107 10 sci.1985;10:357 sci.1985;10:357 PROPN iajs-312 107 11 - - PUNCT iajs-312 107 12 60 60 NUM iajs-312 107 13 . . PUNCT iajs-312 108 1 5 5 NUM iajs-312 108 2 - - PUNCT iajs-312 108 3 inayat inayat PROPN iajs-312 108 4 ur ur PROPN iajs-312 108 5 rahman rahman PROPN iajs-312 108 6 ; ; PUNCT iajs-312 108 7 salman salman PROPN iajs-312 108 8 akbar akbar PROPN iajs-312 108 9 malik malik PROPN iajs-312 108 10 ; ; PUNCT iajs-312 108 11 mohammad mohammad PROPN iajs-312 108 12 bashir bashir PROPN iajs-312 108 13 ; ; PUNCT iajs-312 108 14 rooh rooh PROPN iajs-312 108 15 ullah ullah PROPN iajs-312 108 16 khan khan PROPN iajs-312 108 17 and and CCONJ iajs-312 108 18 muhammad muhammad PROPN iajs-312 108 19 idrees.(2011 idrees.(2011 PROPN iajs-312 108 20 ) ) PUNCT iajs-312 108 21 . . PUNCT iajs-312 109 1 monotherapy monotherapy NOUN iajs-312 109 2 with with ADP iajs-312 109 3 metformin metformin NOUN iajs-312 109 4 or or CCONJ iajs-312 109 5 glimepiride glimepiride NOUN iajs-312 109 6 and and CCONJ iajs-312 109 7 changes change NOUN iajs-312 109 8 in in ADP iajs-312 109 9 serum serum NOUN iajs-312 109 10 sialic sialic ADJ iajs-312 109 11 acid acid NOUN iajs-312 109 12 in in ADP iajs-312 109 13 type type NOUN iajs-312 109 14 2 2 NUM iajs-312 109 15 diabetes diabetes NOUN iajs-312 109 16 mellitus mellitus NOUN iajs-312 109 17 . . PUNCT iajs-312 110 1 british british ADJ iajs-312 110 2 journal journal PROPN iajs-312 110 3 of of ADP iajs-312 110 4 diabetes diabetes NOUN iajs-312 110 5 & & CCONJ iajs-312 110 6 vascular vascular ADJ iajs-312 110 7 disease disease NOUN iajs-312 110 8 2011 2011 NUM iajs-312 110 9 11 11 NUM iajs-312 110 10 : : SYM iajs-312 110 11 137 137 NUM iajs-312 110 12 . . PUNCT iajs-312 111 1 doi doi NOUN iajs-312 111 2 : : PUNCT iajs-312 111 3 10.1177/1474651411412863 10.1177/1474651411412863 NUM iajs-312 111 4 . . PUNCT iajs-312 112 1 6 6 NUM iajs-312 112 2 - - PUNCT iajs-312 112 3 kuma.r kuma.r NOUN iajs-312 112 4 v. v. NOUN iajs-312 112 5 and and CCONJ iajs-312 112 6 sharma sharma PROPN iajs-312 112 7 a. a. PROPN iajs-312 112 8 neutrophils.(2010 neutrophils.(2010 PROPN iajs-312 112 9 ) ) PUNCT iajs-312 112 10 . . PUNCT iajs-312 113 1 cinderella cinderella PROPN iajs-312 113 2 of of ADP iajs-312 113 3 innate innate ADJ iajs-312 113 4 immune immune ADJ iajs-312 113 5 26 26 NUM iajs-312 113 6 . . PUNCT iajs-312 113 7 system system NOUN iajs-312 113 8 . . PUNCT iajs-312 114 1 int int PROPN iajs-312 114 2 immunopharmacol immunopharmacol ADJ iajs-312 114 3 ; ; PUNCT iajs-312 114 4 10 10 NUM iajs-312 114 5 : : SYM iajs-312 114 6 1325 1325 NUM iajs-312 114 7 - - SYM iajs-312 114 8 34 34 NUM iajs-312 114 9 . . PUNCT iajs-312 115 1 7 7 NUM iajs-312 115 2 - - PUNCT iajs-312 115 3 max max PROPN iajs-312 115 4 crispina crispina PROPN iajs-312 115 5 ; ; PUNCT iajs-312 115 6 xiaojie xiaojie PROPN iajs-312 115 7 yua yua PROPN iajs-312 115 8 and and CCONJ iajs-312 115 9 thomas thomas PROPN iajs-312 115 10 a.(2013 a.(2013 PROPN iajs-312 115 11 ) ) PUNCT iajs-312 115 12 . . PUNCT iajs-312 116 1 bowden bowden PROPN iajs-312 116 2 crystal crystal PROPN iajs-312 116 3 structure structure NOUN iajs-312 116 4 of of ADP iajs-312 116 5 sialylated sialylate VERB iajs-312 116 6 igg igg PROPN iajs-312 116 7 fc fc PROPN iajs-312 116 8 . . PUNCT iajs-312 116 9 implications implication NOUN iajs-312 116 10 for for ADP iajs-312 116 11 the the DET iajs-312 116 12 mechanism mechanism NOUN iajs-312 116 13 of of ADP iajs-312 116 14 intravenous intravenous ADJ iajs-312 116 15 immunoglobulin immunoglobulin NOUN iajs-312 116 16 therapy therapy NOUN iajs-312 116 17 . . PUNCT iajs-312 117 1 www.pnas.org/cgi/doi/10.1073 www.pnas.org/cgi/doi/10.1073 X iajs-312 117 2 /pnas.1310657110 /pnas.1310657110 PUNCT iajs-312 117 3 e3544 e3544 PROPN iajs-312 117 4 – – PUNCT iajs-312 117 5 e3546 e3546 VERB iajs-312 117 6 | | ADV iajs-312 117 7 pnas pna NOUN iajs-312 117 8 | | ADV iajs-312 117 9 september september PROPN iajs-312 117 10 17 17 NUM iajs-312 117 11 , , PUNCT iajs-312 117 12 2013 2013 NUM iajs-312 117 13 | | ADV iajs-312 118 1 110 110 NUM iajs-312 118 2 | | ADV iajs-312 118 3 38 38 NUM iajs-312 118 4 . . PUNCT iajs-312 119 1 8 8 NUM iajs-312 119 2 - - PUNCT iajs-312 119 3 sondermann sondermann NOUN iajs-312 119 4 . . PUNCT iajs-312 120 1 p p X iajs-312 120 2 ; ; PUNCT iajs-312 120 3 pincetic pincetic ADJ iajs-312 120 4 . . PUNCT iajs-312 120 5 a. a. NOUN iajs-312 120 6 ; ; PUNCT iajs-312 120 7 maamary maamary NOUN iajs-312 120 8 . . PUNCT iajs-312 121 1 j. j. PROPN iajs-312 121 2 ; ; PUNCT iajs-312 121 3 lammens lammens PROPN iajs-312 121 4 . . PUNCT iajs-312 122 1 k. k. PROPN iajs-312 122 2 and and CCONJ iajs-312 122 3 ravetch ravetch VERB iajs-312 122 4 . . PUNCT iajs-312 123 1 j.v j.v PROPN iajs-312 123 2 . . PUNCT iajs-312 124 1 ( ( PUNCT iajs-312 124 2 2013 2013 NUM iajs-312 124 3 ) ) PUNCT iajs-312 124 4 . . PUNCT iajs-312 125 1 general general ADJ iajs-312 125 2 mechanism mechanism NOUN iajs-312 125 3 for for ADP iajs-312 125 4 modulating modulate VERB iajs-312 125 5 immunoglobulin immunoglobulin NOUN iajs-312 125 6 effector effector NOUN iajs-312 125 7 function.proc.natl.acad function.proc.natl.acad NOUN iajs-312 125 8 sci sci PROPN iajs-312 125 9 usa110:9868 usa110:9868 PROPN iajs-312 125 10 - - PUNCT iajs-312 125 11 9872 9872 NUM iajs-312 125 12 [ [ X iajs-312 125 13 pmc pmc PROPN iajs-312 125 14 free free ADJ iajs-312 125 15 article article NOUN iajs-312 125 16 ] ] X iajs-312 126 1 [ [ X iajs-312 126 2 pumbmed pumbmed X iajs-312 126 3 ] ] PUNCT iajs-312 126 4 . . PUNCT iajs-312 127 1 9 9 NUM iajs-312 127 2 - - PUNCT iajs-312 127 3 varki varki NOUN iajs-312 127 4 .a.and .a.and PUNCT iajs-312 128 1 crocker crocker PROPN iajs-312 128 2 . . PUNCT iajs-312 129 1 p.r p.r PROPN iajs-312 129 2 . . PROPN iajs-312 129 3 ( ( PUNCT iajs-312 129 4 2009 2009 NUM iajs-312 129 5 ) ) PUNCT iajs-312 129 6 . . PUNCT iajs-312 130 1 i i PRON iajs-312 130 2 - - PUNCT iajs-312 130 3 type type NOUN iajs-312 130 4 lectins lectin NOUN iajs-312 130 5 . . PUNCT iajs-312 131 1 in in ADP iajs-312 131 2 varki varki PROPN iajs-312 131 3 , , PUNCT iajs-312 131 4 a. a. NOUN iajs-312 131 5 ; ; PUNCT iajs-312 131 6 cummings cummings PROPN iajs-312 131 7 , , PUNCT iajs-312 131 8 r.d r.d PROPN iajs-312 131 9 . . PROPN iajs-312 131 10 ; ; PUNCT iajs-312 131 11 esko esko PROPN iajs-312 131 12 , , PUNCT iajs-312 131 13 j.d j.d PROPN iajs-312 131 14 . . PROPN iajs-312 131 15 ; ; PUNCT iajs-312 131 16 freeze.h.h freeze.h.h PROPN iajs-312 131 17 . . PUNCT iajs-312 131 18 ; ; PUNCT iajs-312 131 19 stanley stanley NOUN iajs-312 131 20 , , PUNCT iajs-312 131 21 p. p. NOUN iajs-312 131 22 ; ; PUNCT iajs-312 131 23 bertozzi.c.r bertozzi.c.r PROPN iajs-312 131 24 . . PUNCT iajs-312 131 25 ; ; PUNCT iajs-312 131 26 hart.g.w.and hart.g.w.and PROPN iajs-312 131 27 etzler.m.e etzler.m.e PROPN iajs-312 131 28 . . PROPN iajs-312 131 29 ; ; PUNCT iajs-312 131 30 editors editor NOUN iajs-312 131 31 essentials essential NOUN iajs-312 131 32 of of ADP iajs-312 131 33 glycobiology glycobiology NOUN iajs-312 131 34 . . PUNCT iajs-312 132 1 cold cold ADJ iajs-312 132 2 spring spring NOUN iajs-312 132 3 harbor harbor NOUN iajs-312 132 4 , , PUNCT iajs-312 132 5 ny ny PROPN iajs-312 132 6 : : PUNCT iajs-312 132 7 cold cold ADJ iajs-312 132 8 spring spring NOUN iajs-312 132 9 harbor harbor PROPN iajs-312 132 10 laboratory laboratory NOUN iajs-312 132 11 press press NOUN iajs-312 132 12 . . PUNCT iajs-312 133 1 p. p. NOUN iajs-312 133 2                                                     SPACE iajs-312 133 3 10 10 NUM iajs-312 133 4 - - PUNCT iajs-312 133 5 ali ali PROPN iajs-312 133 6 özcan özcan PROPN iajs-312 133 7 ; ; PUNCT iajs-312 133 8 aykan aykan PROPN iajs-312 133 9 yücel yücel PROPN iajs-312 133 10 ; ; PUNCT iajs-312 133 11 volkan volkan PROPN iajs-312 133 12 noyan noyan PROPN iajs-312 133 13 ; ; PUNCT iajs-312 133 14 nevin nevin PROPN iajs-312 133 15 sağsöz sağsöz PROPN iajs-312 133 16 and and CCONJ iajs-312 133 17 osman osman PROPN iajs-312 133 18 çağlayan çağlayan PROPN iajs-312 133 19 . . PUNCT iajs-312 134 1 ( ( PUNCT iajs-312 134 2 2012).total 2012).total NUM iajs-312 134 3 and and CCONJ iajs-312 134 4 lipid lipid NOUN iajs-312 134 5 bound bind VERB iajs-312 134 6 sialic sialic ADJ iajs-312 134 7 acid acid NOUN iajs-312 134 8 levels level NOUN iajs-312 134 9 in in ADP iajs-312 134 10 patients patient NOUN iajs-312 134 11 with with ADP iajs-312 134 12 polycystic polycystic ADJ iajs-312 134 13 ovary ovary ADJ iajs-312 134 14 syndrome syndrome NOUN iajs-312 134 15 . . PUNCT iajs-312 135 1 journal journal ADJ iajs-312 135 2 turkish turkish ADJ iajs-312 135 3 - - PUNCT iajs-312 135 4 german german ADJ iajs-312 135 5 gynecol gynecol NOUN iajs-312 135 6 assoc assoc NOUN iajs-312 135 7 ; ; PUNCT iajs-312 135 8 13 13 NUM iajs-312 135 9 : : SYM iajs-312 135 10 79 79 NUM iajs-312 135 11 - - SYM iajs-312 135 12 84 84 NUM iajs-312 135 13 . . PUNCT iajs-312 136 1 11 11 NUM iajs-312 136 2 - - PUNCT iajs-312 136 3 bayrak.t bayrak.t PRON iajs-312 136 4 . . PUNCT iajs-312 136 5 ; ; PUNCT iajs-312 136 6 bayrak.a bayrak.a PROPN iajs-312 136 7 . . PROPN iajs-312 136 8 ; ; PUNCT iajs-312 137 1 demirpençe demirpençe PROPN iajs-312 137 2 , , PUNCT iajs-312 137 3 e.and e.and PROPN iajs-312 137 4 kilinç.k.(2010 kilinç.k.(2010 NOUN iajs-312 137 5 ) ) PUNCT iajs-312 137 6 . . PUNCT iajs-312 138 1 purification purification NOUN iajs-312 138 2 and and CCONJ iajs-312 138 3 kinetic kinetic ADJ iajs-312 138 4 properties property NOUN iajs-312 138 5 of of ADP iajs-312 138 6 rabbit rabbit NOUN iajs-312 138 7 liver liver NOUN iajs-312 138 8 paraoxonase paraoxonase NOUN iajs-312 138 9 1 1 NUM iajs-312 138 10 . . PUNCT iajs-312 139 1 j j PROPN iajs-312 139 2 chromatogr chromatogr PROPN iajs-312 139 3 b b PROPN iajs-312 139 4 analyt analyt PROPN iajs-312 139 5 technol technol PROPN iajs-312 139 6 biomed biome VERB iajs-312 139 7 life life NOUN iajs-312 139 8 sci.;878:1791–5 sci.;878:1791–5 PROPN iajs-312 139 9 . . PUNCT iajs-312 139 10                                             SPACE iajs-312 139 11 12 12 NUM iajs-312 139 12 - - PUNCT iajs-312 139 13 jayakumari jayakumari PROPN iajs-312 139 14 , , PUNCT iajs-312 139 15 n. n. PROPN iajs-312 139 16 & & CCONJ iajs-312 139 17 thejaseebai thejaseebai PROPN iajs-312 139 18 , , PUNCT iajs-312 139 19 g.(2009 g.(2009 PROPN iajs-312 139 20 ) ) PUNCT iajs-312 139 21 . . PUNCT iajs-312 140 1 high high ADJ iajs-312 140 2 prevalence prevalence NOUN iajs-312 140 3 of of ADP iajs-312 140 4 low low ADJ iajs-312 140 5 serum serum NOUN iajs-312 140 6 paraoxonase-1 paraoxonase-1 PROPN iajs-312 140 7 in in ADP iajs-312 140 8 subjects subject NOUN iajs-312 140 9 with with ADP iajs-312 140 10 coronary coronary ADJ iajs-312 140 11 artery artery NOUN iajs-312 140 12 disease disease NOUN iajs-312 140 13 . . PUNCT iajs-312 141 1 journal journal NOUN iajs-312 141 2 of of ADP iajs-312 141 3 clinical clinical ADJ iajs-312 141 4 biochemistry biochemistry NOUN iajs-312 141 5 and and CCONJ iajs-312 141 6 nutrition.45.278 nutrition.45.278 NOUN iajs-312 141 7 – – PUNCT iajs-312 141 8 284.(doi:10jcbn.08 284.(doi:10jcbn.08 NUM iajs-312 141 9 - - PUNCT iajs-312 141 10 255/3164 255/3164 NUM iajs-312 141 11 ) ) PUNCT iajs-312 141 12 . . PUNCT iajs-312 142 1 13 13 NUM iajs-312 142 2 - - PUNCT iajs-312 142 3 mohamadin.a.m mohamadin.a.m PROPN iajs-312 142 4 ; ; PUNCT iajs-312 142 5 habib.f.a habib.f.a PROPN iajs-312 142 6 . . PUNCT iajs-312 142 7 & & CCONJ iajs-312 142 8 elahi.t.f.(2010 elahi.t.f.(2010 PROPN iajs-312 142 9 ) ) PUNCT iajs-312 142 10 . . PUNCT iajs-312 143 1 serum serum PROPN iajs-312 143 2 paraoxonase paraoxonase PROPN iajs-312 143 3 1 1 NUM iajs-312 143 4 activity activity NOUN iajs-312 143 5 and and CCONJ iajs-312 143 6 oxidant oxidant ADJ iajs-312 143 7 / / SYM iajs-312 143 8 antioxidant antioxidant ADJ iajs-312 143 9 status status NOUN iajs-312 143 10 in in ADP iajs-312 143 11 saudi saudi ADJ iajs-312 143 12 women woman NOUN iajs-312 143 13 with with ADP iajs-312 143 14 polycystic polycystic ADJ iajs-312 143 15 ovary ovary ADJ iajs-312 143 16 syndrome syndrome NOUN iajs-312 143 17 . . PUNCT iajs-312 144 1 pathophysiology.17189–196.doi:10.1016 pathophysiology.17189–196.doi:10.1016 PROPN iajs-312 144 2 / / SYM iajs-312 144 3 j.pathophys.11.004 j.pathophys.11.004 PROPN iajs-312 144 4 . . PUNCT iajs-312 144 5 14 14 NUM iajs-312 144 6 - - PUNCT iajs-312 144 7 varga varga PROPN iajs-312 144 8 , , PUNCT iajs-312 144 9 e. e. PROPN iajs-312 144 10 ; ; PUNCT iajs-312 144 11 seres sere NOUN iajs-312 144 12 , , PUNCT iajs-312 144 13 i. i. NOUN iajs-312 144 14 ; ; PUNCT iajs-312 144 15 harangi;m harangi;m PROPN iajs-312 144 16 . . PUNCT iajs-312 144 17 ; ; PUNCT iajs-312 144 18 sztanek;f sztanek;f PROPN iajs-312 144 19 . . PROPN iajs-312 144 20 ; ; PUNCT iajs-312 144 21 asztalos;l asztalos;l PROPN iajs-312 144 22 . . PROPN iajs-312 144 23 ; ; PUNCT iajs-312 144 24 locsey locsey NOUN iajs-312 144 25 , , PUNCT iajs-312 144 26 l. l. PROPN iajs-312 144 27 ; ; PUNCT iajs-312 144 28 borbas borbas PROPN iajs-312 144 29 , , PUNCT iajs-312 144 30 b. b. PROPN iajs-312 144 31 ; ; PUNCT iajs-312 144 32 szegedi szegedi PROPN iajs-312 144 33 , , PUNCT iajs-312 144 34 j j PROPN iajs-312 144 35 ; ; PUNCT iajs-312 144 36 karpati.i karpati.i PROPN iajs-312 144 37 . . PUNCT iajs-312 144 38 & & CCONJ iajs-312 144 39 paragh.g.(2009).serum paragh.g.(2009).serum PROPN iajs-312 144 40 cystatin cystatin PROPN iajs-312 144 41 c c PROPN iajs-312 144 42 is be AUX iajs-312 144 43 a a DET iajs-312 144 44 determinant determinant NOUN iajs-312 144 45 of of ADP iajs-312 144 46 paraoxonase paraoxonase NOUN iajs-312 144 47 activity activity NOUN iajs-312 144 48 in in ADP iajs-312 144 49 hemodialyzed hemodialyze VERB iajs-312 144 50 and and CCONJ iajs-312 144 51 renal renal ADJ iajs-312 144 52 transplanted transplanted ADJ iajs-312 144 53 patients patient NOUN iajs-312 144 54 . . PUNCT iajs-312 145 1 disease disease NOUN iajs-312 145 2 markers marker NOUN iajs-312 145 3 ; ; PUNCT iajs-312 145 4 26 26 NUM iajs-312 145 5 . . PUNCT iajs-312 146 1 141–148 141–148 NUM iajs-312 146 2 . . PUNCT iajs-312 147 1 ( ( PUNCT iajs-312 147 2 doi:103233)./dma-2009 doi:103233)./dma-2009 X iajs-312 147 3 - - SYM iajs-312 147 4 0624 0624 NUM iajs-312 147 5 ) ) PUNCT iajs-312 147 6 . . PUNCT iajs-312 148 1 15 15 NUM iajs-312 148 2 - - PUNCT iajs-312 148 3 mohammad mohammad PROPN iajs-312 148 4 hashemi hashemi NOUN iajs-312 148 5 ; ; PUNCT iajs-312 148 6 dor dor PROPN iajs-312 148 7 mohammad mohammad PROPN iajs-312 148 8 ; ; PUNCT iajs-312 148 9 kordi kordi NOUN iajs-312 148 10 - - PUNCT iajs-312 148 11 tamandani1 tamandani1 PROPN iajs-312 148 12 ; ; PUNCT iajs-312 148 13 nooshin nooshin NOUN iajs-312 148 14 sharifi1 sharifi1 PROPN iajs-312 148 15 ; ; PUNCT iajs-312 148 16 abdolkarim abdolkarim VERB iajs-312 148 17 moazeni moazeni NOUN iajs-312 148 18 - - PUNCT iajs-312 148 19 roodi roodi NOUN iajs-312 148 20 ; ; PUNCT iajs-312 148 21 mahmoud mahmoud PROPN iajs-312 148 22 - - PUNCT iajs-312 148 23 ali ali PROPN iajs-312 148 24 kaykhaei kaykhaei PROPN iajs-312 148 25 ; ; PUNCT iajs-312 148 26 behzad behzad PROPN iajs-312 148 27 narouie narouie PROPN iajs-312 148 28 and and CCONJ iajs-312 148 29 adam adam PROPN iajs-312 148 30 torkmanzehi torkmanzehi NOUN iajs-312 148 31 .(2011 .(2011 NUM iajs-312 148 32 ) ) PUNCT iajs-312 148 33 . . PUNCT iajs-312 149 1 serum serum PROPN iajs-312 149 2 paraoxonase paraoxonase PROPN iajs-312 149 3 and and CCONJ iajs-312 149 4 arylesterase arylesterase ADJ iajs-312 149 5 activities activity NOUN iajs-312 149 6 in in ADP iajs-312 149 7 metabolic metabolic NOUN iajs-312 149 8 syndrome syndrome NOUN iajs-312 149 9 in in ADP iajs-312 149 10 zahedan zahedan PROPN iajs-312 149 11 , , PUNCT iajs-312 149 12 southeast southeast ADJ iajs-312 149 13 iran.european iran.european ADJ iajs-312 149 14 journal journal NOUN iajs-312 149 15 of of ADP iajs-312 149 16 endocrinology endocrinology NOUN iajs-312 149 17 . . PUNCT iajs-312 150 1 164 164 NUM iajs-312 150 2 : : PUNCT iajs-312 151 1 219–222 219–222 NUM iajs-312 151 2 . . PUNCT iajs-312 151 3 16 16 NUM iajs-312 151 4 - - PUNCT iajs-312 151 5 dokras.a.(2008).cardiovascular dokras.a.(2008).cardiovascular ADJ iajs-312 151 6 disease disease NOUN iajs-312 151 7 risk risk NOUN iajs-312 151 8 factors factor NOUN iajs-312 151 9 in in ADP iajs-312 151 10 polycystic polycystic ADJ iajs-312 151 11 ovary ovary ADJ iajs-312 151 12 syndrome syndrome NOUN iajs-312 151 13 . . PUNCT iajs-312 152 1 seminars seminar NOUN iajs-312 152 2 in in ADP iajs-312 152 3 reproductivemedicine26.39–44 reproductivemedicine26.39–44 PROPN iajs-312 152 4 doi:10.1055 doi:10.1055 NOUN iajs-312 152 5 / / SYM iajs-312 152 6 s-2007 s-2007 ADJ iajs-312 152 7 - - PUNCT iajs-312 152 8 992923 992923 NUM iajs-312 152 9 17 17 NUM iajs-312 152 10 - - PUNCT iajs-312 152 11 repaci repaci NOUN iajs-312 152 12 , , PUNCT iajs-312 152 13 .a .a PROPN iajs-312 152 14 . . PUNCT iajs-312 152 15 ; ; PUNCT iajs-312 152 16 gambineri gambineri NOUN iajs-312 152 17 , , PUNCT iajs-312 152 18 a. a. PROPN iajs-312 152 19 & & CCONJ iajs-312 152 20 pasquali pasquali PROPN iajs-312 152 21 r. r. PROPN iajs-312 152 22 2011.the 2011.the DET iajs-312 152 23 role role NOUN iajs-312 152 24 of of ADP iajs-312 152 25 low low ADJ iajs-312 152 26 - - PUNCT iajs-312 152 27 grade grade NOUN iajs-312 152 28 inflammation inflammation NOUN iajs-312 152 29 in in ADP iajs-312 152 30 the the DET iajs-312 152 31 polycystic polycystic ADJ iajs-312 152 32 ovary ovary ADJ iajs-312 152 33 syndrome syndrome NOUN iajs-312 152 34 . . PUNCT iajs-312 153 1 molecular molecular ADJ iajs-312 153 2 and and CCONJ iajs-312 153 3 cellular cellular ADJ iajs-312 153 4 endoc endoc ADJ iajs-312 153 5 rhinology rhinology NOUN iajs-312 153 6 . . PUNCT iajs-312 154 1 2011 2011 NUM iajs-312 154 2 ; ; PUNCT iajs-312 154 3 335 335 NUM iajs-312 154 4 , , PUNCT iajs-312 154 5 30–41 30–41 NUM iajs-312 154 6 . . PUNCT iajs-312 155 1 ( ( PUNCT iajs-312 155 2 doi:10.1016 doi:10.1016 PROPN iajs-312 155 3 / / SYM iajs-312 155 4 j.mce.2010.08.002 j.mce.2010.08.002 NOUN iajs-312 155 5 ) ) PUNCT iajs-312 155 6 . . PUNCT iajs-312 156 1 18 18 NUM iajs-312 156 2 - - PUNCT iajs-312 156 3 precourt precourt NOUN iajs-312 156 4 , , PUNCT iajs-312 156 5 l.p l.p PROPN iajs-312 156 6 ; ; PUNCT iajs-312 156 7 amre.d.;denis.mc.;lavoie.jc.;delvin amre.d.;denis.mc.;lavoie.jc.;delvin PROPN iajs-312 156 8 , , PUNCT iajs-312 156 9 e.;seidman e.;seidman NOUN iajs-312 156 10 , , PUNCT iajs-312 156 11 e e NOUN iajs-312 156 12 and and CCONJ iajs-312 156 13 levy levy VERB iajs-312 156 14 e.(2010 e.(2010 NOUN iajs-312 156 15 ) ) PUNCT iajs-312 156 16 .the .the PUNCT iajs-312 156 17 three three NUM iajs-312 156 18 - - PUNCT iajs-312 156 19 gene gene NOUN iajs-312 156 20 paraoxonase paraoxonase NOUN iajs-312 156 21 family family NOUN iajs-312 156 22 : : PUNCT iajs-312 156 23 physiologic physiologic ADJ iajs-312 156 24 roles role NOUN iajs-312 156 25 actions action NOUN iajs-312 156 26 and and CCONJ iajs-312 156 27 regulation regulation NOUN iajs-312 156 28 . . PUNCT iajs-312 157 1 atherosclerosis;214 atherosclerosis;214 ADP iajs-312 157 2 20–36 20–36 NUM iajs-312 157 3 . . PUNCT iajs-312 158 1 ( ( PUNCT iajs-312 158 2 doi:10 doi:10 X iajs-312 158 3 . . PUNCT iajs-312 159 1 j.atherosclerosis j.atherosclerosis PROPN iajs-312 159 2 2010.08.076 2010.08.076 NUM iajs-312 159 3 ) ) PUNCT iajs-312 159 4 . . PUNCT iajs-312 160 1 475 475 NUM iajs-312 160 2 | | ADV iajs-312 160 3 chemistry chemistry NOUN iajs-312 160 4 2014 2014 NUM iajs-312 160 5 ) ) PUNCT iajs-312 160 6 عام عام ADP iajs-312 160 7 3(العدد 3(العدد NUM iajs-312 160 8 27المجلد 27المجلد NUM iajs-312 160 9 مجلة مجلة VERB iajs-312 160 10 إبن إبن NOUN iajs-312 160 11 الھيثم الھيثم NOUN iajs-312 160 12 للعلوم للعلوم NOUN iajs-312 160 13 الصرفة الصرفة NOUN iajs-312 161 1 و و PRON iajs-312 161 2 التطبيقية التطبيقية ADJ iajs-312 161 3 ibn ibn PROPN iajs-312 161 4 al al PROPN iajs-312 161 5 - - PUNCT iajs-312 161 6 haitham haitham PROPN iajs-312 161 7 jour jour X iajs-312 161 8 . . PROPN iajs-312 161 9 for for ADP iajs-312 161 10 pure pure ADJ iajs-312 161 11 & & CCONJ iajs-312 161 12 appl appl PROPN iajs-312 161 13 . . PUNCT iajs-312 162 1 sci sci PROPN iajs-312 162 2 . . PUNCT iajs-312 162 3 vol vol NOUN iajs-312 162 4 . . PROPN iajs-312 163 1 27 27 NUM iajs-312 163 2 ( ( PUNCT iajs-312 163 3 3 3 NUM iajs-312 163 4 ) ) PUNCT iajs-312 163 5 2014 2014 NUM iajs-312 163 6 19 19 NUM iajs-312 163 7 - - PUNCT iajs-312 163 8 camps camp NOUN iajs-312 163 9 , , PUNCT iajs-312 163 10 j. j. PROPN iajs-312 163 11 ; ; PUNCT iajs-312 163 12 marsillach marsillach NOUN iajs-312 163 13 , , PUNCT iajs-312 163 14 j. j. PROPN iajs-312 163 15 & & CCONJ iajs-312 163 16 joven.j.(2009 joven.j.(2009 NUM iajs-312 163 17 ) ) PUNCT iajs-312 163 18 . . PUNCT iajs-312 164 1 the the DET iajs-312 164 2 paraoxonases paraoxonase NOUN iajs-312 164 3 : : PUNCT iajs-312 164 4 role role NOUN iajs-312 164 5 in in ADP iajs-312 164 6 human human ADJ iajs-312 164 7 diseases disease NOUN iajs-312 164 8 and and CCONJ iajs-312 164 9 methodological methodological ADJ iajs-312 164 10 difficulties difficulty NOUN iajs-312 164 11 in in ADP iajs-312 164 12 measurement measurement NOUN iajs-312 164 13 . . PUNCT iajs-312 165 1 critical critical ADJ iajs-312 165 2 reviews review NOUN iajs-312 165 3 in in ADP iajs-312 165 4 clinical clinical ADJ iajs-312 165 5 laboratory laboratory NOUN iajs-312 165 6 sciences science NOUN iajs-312 165 7 . . PUNCT iajs-312 166 1 46 46 NUM iajs-312 166 2 83–106 83–106 NUM iajs-312 166 3 . . PUNCT iajs-312 166 4 ( ( PUNCT iajs-312 166 5 doi:10 doi:10 PROPN iajs-312 166 6 . . PUNCT iajs-312 167 1 1080/10408360802610878 1080/10408360802610878 NUM iajs-312 167 2 . . PUNCT iajs-312 167 3 ) ) PUNCT iajs-312 167 4 . . PUNCT iajs-312 167 5                                                             SPACE iajs-312 168 1 20 20 NUM iajs-312 168 2 - - PUNCT iajs-312 168 3 xiaoxiawang xiaoxiawang PROPN iajs-312 168 4 ; ; PUNCT iajs-312 168 5 renee renee PROPN iajs-312 168 6 chow;liwen chow;liwen PROPN iajs-312 168 7 deng deng PROPN iajs-312 168 8 ; ; PUNCT iajs-312 168 9 dan dan PROPN iajs-312 168 10 anderson anderson PROPN iajs-312 168 11 ; ; PUNCT iajs-312 168 12 noelweidner noelweidner ADV iajs-312 168 13 ; ; PUNCT iajs-312 168 14 andrew andrew PROPN iajs-312 168 15 k k PROPN iajs-312 168 16 ; ; PUNCT iajs-312 168 17 godwin godwin PROPN iajs-312 168 18 chanda chanda PROPN iajs-312 168 19 bewtra bewtra PROPN iajs-312 168 20 ; ; PUNCT iajs-312 168 21 albert albert PROPN iajs-312 168 22 zlotnik zlotnik PROPN iajs-312 168 23 ; ; PUNCT iajs-312 168 24 jack jack PROPN iajs-312 168 25 bui bui PROPN iajs-312 168 26 ; ; PUNCT iajs-312 168 27 ajit ajit NOUN iajs-312 168 28 , , PUNCT iajs-312 168 29 varki1 varki1 NOUN iajs-312 168 30 and and CCONJ iajs-312 168 31 nissi nissi ADJ iajs-312 168 32 varki varki NOUN iajs-312 168 33 . . PUNCT iajs-312 169 1 ( ( PUNCT iajs-312 169 2 2011 2011 NUM iajs-312 169 3 ) ) PUNCT iajs-312 169 4 . . PUNCT iajs-312 170 1 expression expression NOUN iajs-312 170 2 of of ADP iajs-312 170 3 siglec-11 siglec-11 PROPN iajs-312 170 4 by by ADP iajs-312 170 5 human human ADJ iajs-312 170 6 and and CCONJ iajs-312 170 7 chimpanzee chimpanzee ADJ iajs-312 170 8 ovarian ovarian ADJ iajs-312 170 9 stromal stromal ADJ iajs-312 170 10 cells cell NOUN iajs-312 170 11 , , PUNCT iajs-312 170 12 with with ADP iajs-312 170 13 uniquely uniquely ADV iajs-312 170 14 human human ADJ iajs-312 170 15 ligands ligand NOUN iajs-312 170 16 : : PUNCT iajs-312 170 17 implications implication NOUN iajs-312 170 18 for for ADP iajs-312 170 19 human human ADJ iajs-312 170 20 ovarian ovarian ADJ iajs-312 170 21 physiology physiology NOUN iajs-312 170 22 and and CCONJ iajs-312 170 23 pathology.glycobiology pathology.glycobiology NOUN iajs-312 170 24 . . PUNCT iajs-312 171 1 21 21 NUM iajs-312 171 2 . . NOUN iajs-312 171 3 8 8 NUM iajs-312 171 4 . . X iajs-312 171 5 1038–1048 1038–1048 NUM iajs-312 171 6 , , PUNCT iajs-312 171 7 ( ( PUNCT iajs-312 171 8 2011 2011 NUM iajs-312 171 9 ) ) PUNCT iajs-312 171 10 . . PUNCT iajs-312 172 1 doi:10.1093 doi:10.1093 NOUN iajs-312 172 2 / / SYM iajs-312 172 3 glycob glycob PROPN iajs-312 172 4 / / SYM iajs-312 172 5 cwr039 cwr039 NOUN iajs-312 172 6 advance advance NOUN iajs-312 172 7 access access NOUN iajs-312 172 8 publication publication NOUN iajs-312 172 9 on on ADP iajs-312 172 10 april april PROPN iajs-312 172 11 4 4 NUM iajs-312 172 12 , , PUNCT iajs-312 172 13 2011 2011 NUM iajs-312 172 14 . . PUNCT iajs-312 173 1 21- 21- NUM iajs-312 173 2     SPACE iajs-312 173 3 bickerton bickerton NOUN iajs-312 173 4 , , PUNCT iajs-312 173 5 a. a. PROPN iajs-312 173 6 s.t s.t PROPN iajs-312 173 7 ; ; PUNCT iajs-312 173 8 clark clark PROPN iajs-312 173 9 , , PUNCT iajs-312 173 10 n. n. PROPN iajs-312 173 11 ; ; PUNCT iajs-312 173 12     SPACE iajs-312 173 13 meeking meeking NOUN iajs-312 173 14 , , PUNCT iajs-312 173 15 d. d. PROPN iajs-312 173 16 ; ; PUNCT iajs-312 173 17     SPACE iajs-312 173 18 shaw shaw PROPN iajs-312 173 19 , , PUNCT iajs-312 173 20 k.m k.m PROPN iajs-312 173 21 . . PROPN iajs-312 173 22 ; ; PUNCT iajs-312 173 23     SPACE iajs-312 173 24 crook crook NOUN iajs-312 173 25 , , PUNCT iajs-312 173 26 m. m. NOUN iajs-312 173 27 ; ; PUNCT iajs-312 173 28     SPACE iajs-312 173 29 lumb lumb ADJ iajs-312 173 30 , , PUNCT iajs-312 173 31 p. p. NOUN iajs-312 173 32 ; ; PUNCT iajs-312 173 33 turner turner PROPN iajs-312 173 34 , , PUNCT iajs-312 173 35 c. c. PROPN iajs-312 173 36 ; ; PUNCT iajs-312 173 37 and and CCONJ iajs-312 173 38     SPACE iajs-312 173 39 cummings cummings PROPN iajs-312 173 40 , , PUNCT iajs-312 173 41 m. m. PROPN iajs-312 173 42 h. h. PROPN iajs-312 173 43 ; ; PUNCT iajs-312 173 44 ( ( PUNCT iajs-312 173 45 2005).cardiovascular 2005).cardiovascular NUM iajs-312 173 46 risk risk NOUN iajs-312 173 47 in in ADP iajs-312 173 48 women woman NOUN iajs-312 173 49 with with ADP iajs-312 173 50 polycystic polycystic ADJ iajs-312 173 51 ovarian ovarian ADJ iajs-312 173 52 syndrome syndrome NOUN iajs-312 173 53 ( ( PUNCT iajs-312 173 54 pcos pcos PROPN iajs-312 173 55 ) ) PUNCT iajs-312 174 1 j j PROPN iajs-312 174 2 clin clin PROPN iajs-312 174 3 pathol;58:151–154 pathol;58:151–154 PROPN iajs-312 174 4 . . PUNCT iajs-312 175 1 doi doi NOUN iajs-312 175 2 : : PUNCT iajs-312 175 3 10.1136 10.1136 NUM iajs-312 175 4 / / SYM iajs-312 175 5 jcp.2003.015271 jcp.2003.015271 NOUN iajs-312 175 6 . . PUNCT iajs-312 176 1 22gonzále 22gonzále PROPN iajs-312 176 2 , , PUNCT iajs-312 176 3 f.z f.z NOUN iajs-312 176 4 ; ; PUNCT iajs-312 176 5 rote rote ADJ iajs-312 176 6 , , PUNCT iajs-312 176 7 n.s n.s PROPN iajs-312 176 8 . . PROPN iajs-312 176 9 ; ; PUNCT iajs-312 177 1 minium minium PROPN iajs-312 177 2 , , PUNCT iajs-312 177 3 j. j. PROPN iajs-312 177 4 ; ; PUNCT iajs-312 177 5 kirwan kirwan PROPN iajs-312 177 6 , , PUNCT iajs-312 177 7 l.p.;(2009 l.p.;(2009 PROPN iajs-312 177 8 ) ) PUNCT iajs-312 177 9 . . PUNCT iajs-312 178 1 evidence evidence NOUN iajs-312 178 2 of of ADP iajs-312 178 3 proatherogenic proatherogenic ADJ iajs-312 178 4 inflammation inflammation NOUN iajs-312 178 5 in in ADP iajs-312 178 6 polycystic polycystic ADJ iajs-312 178 7 ovary ovary ADJ iajs-312 178 8 syndrome syndrome NOUN iajs-312 178 9 , , PUNCT iajs-312 178 10 metabolism metabolism NOUN iajs-312 178 11 58(2009).954 58(2009).954 NUM iajs-312 178 12 - - SYM iajs-312 178 13 962 962 NUM iajs-312 178 14 . . PUNCT iajs-312 179 1 23ahmed 23ahmed NUM iajs-312 179 2 , , PUNCT iajs-312 179 3 m. m. NOUN iajs-312 179 4 ; ; PUNCT iajs-312 179 5 mohamadin mohamadin VERB iajs-312 179 6 , , PUNCT iajs-312 179 7 fawzia fawzia PROPN iajs-312 179 8 , , PUNCT iajs-312 179 9 a. a. NOUN iajs-312 179 10 ; ; PUNCT iajs-312 179 11 habib habib PROPN iajs-312 179 12 and and CCONJ iajs-312 179 13 thoraya thoraya PROPN iajs-312 179 14 fadul fadul PROPN iajs-312 179 15 elahi elahi PROPN iajs-312 179 16 . . PUNCT iajs-312 180 1 ( ( PUNCT iajs-312 180 2 2010 2010 NUM iajs-312 180 3 ) ) PUNCT iajs-312 180 4 . . PUNCT iajs-312 181 1 serum serum PROPN iajs-312 181 2 paraoxonase paraoxonase PROPN iajs-312 181 3 1 1 NUM iajs-312 181 4 activity activity NOUN iajs-312 181 5 and and CCONJ iajs-312 181 6 oxidant oxidant ADJ iajs-312 181 7 / / SYM iajs-312 181 8 antioxidant antioxidant ADJ iajs-312 181 9 status status NOUN iajs-312 181 10 in in ADP iajs-312 181 11 saudi saudi ADJ iajs-312 181 12 women woman NOUN iajs-312 181 13 with with ADP iajs-312 181 14 polycystic polycystic ADJ iajs-312 181 15 ovary ovary NOUN iajs-312 181 16 syndrome.pathophysiology.17:189–196 syndrome.pathophysiology.17:189–196 PROPN iajs-312 181 17 . . PUNCT iajs-312 181 18                                                                                                                               SPACE iajs-312 181 19 24fenkci 24fenkci NUM iajs-312 181 20 , , PUNCT iajs-312 181 21 iv iv NUM iajs-312 181 22 ; ; PUNCT iajs-312 181 23 serteser sertes ADJ iajs-312 181 24 , , PUNCT iajs-312 181 25 m m PROPN iajs-312 181 26 ; ; PUNCT iajs-312 181 27 fenkci fenkci ADJ iajs-312 181 28 , , PUNCT iajs-312 181 29 s s PART iajs-312 181 30 and and CCONJ iajs-312 181 31 kose.s kose.s PROPN iajs-312 181 32 .(2007 .(2007 PUNCT iajs-312 181 33 ) ) PUNCT iajs-312 182 1 .paraoxonase .paraoxonase CCONJ iajs-312 182 2 levels level NOUN iajs-312 182 3 in in ADP iajs-312 182 4 women woman NOUN iajs-312 182 5 with with ADP iajs-312 182 6 polycystic polycystic ADJ iajs-312 182 7 ovary ovary ADJ iajs-312 182 8 syndrome syndrome NOUN iajs-312 182 9 . . PUNCT iajs-312 183 1 j j PROPN iajs-312 183 2 reprod reprod PROPN iajs-312 183 3 med me VERB iajs-312 183 4 52:879 52:879 NUM iajs-312 183 5 - - PUNCT iajs-312 183 6 883 883 NUM iajs-312 183 7 . . PUNCT iajs-312 184 1 25- 25- NUM iajs-312 184 2     SPACE iajs-312 184 3 soran.h soran.h PROPN iajs-312 184 4 . . PUNCT iajs-312 184 5 ; ; PUNCT iajs-312 184 6     SPACE iajs-312 184 7 younis younis PROPN iajs-312 184 8 , , PUNCT iajs-312 184 9 n.n n.n PROPN iajs-312 184 10 . . PROPN iajs-312 184 11 ; ; PUNCT iajs-312 184 12 charlton charlton NOUN iajs-312 184 13 - - PUNCT iajs-312 184 14 menys menys PROPN iajs-312 184 15 , , PUNCT iajs-312 184 16 v.and v.and VERB iajs-312 184 17 durrington durrington NOUN iajs-312 184 18 .p.(2009 .p.(2009 NUM iajs-312 184 19 ) ) PUNCT iajs-312 184 20 . . PUNCT iajs-312 185 1 variation variation NOUN iajs-312 185 2 in in ADP iajs-312 185 3 paraoxonase-1 paraoxonase-1 NUM iajs-312 185 4 activity activity NOUN iajs-312 185 5 and and CCONJ iajs-312 185 6 atherosclerosis atherosclerosis NOUN iajs-312 185 7 , , PUNCT iajs-312 185 8 curr curr PROPN iajs-312 185 9 . . PUNCT iajs-312 186 1 opin opin NOUN iajs-312 186 2 . . PUNCT iajs-312 187 1 lipidol lipidol VERB iajs-312 187 2 . . PUNCT iajs-312 188 1 20.(2009).265 20.(2009).265 NOUN iajs-312 188 2 - - SYM iajs-312 188 3 274 274 NUM iajs-312 188 4 . . PUNCT iajs-312 189 1 26 26 NUM iajs-312 189 2 - - PUNCT iajs-312 189 3 jean jean PROPN iajs-312 189 4 l.b l.b PROPN iajs-312 189 5 ; ; PUNCT iajs-312 189 6 joseph joseph PROPN iajs-312 189 7 l.j l.j PROPN iajs-312 189 8 and and CCONJ iajs-312 189 9 julie julie PROPN iajs-312 189 10 v.s. v.s. PROPN iajs-312 189 11 ( ( PUNCT iajs-312 189 12 2012 2012 NUM iajs-312 189 13 ) ) PUNCT iajs-312 189 14 . . PUNCT iajs-312 190 1 dermatology dermatology NOUN iajs-312 190 2 . . PUNCT iajs-312 191 1 3th 3th ADJ iajs-312 191 2 ed ed NOUN iajs-312 191 3 . . PUNCT iajs-312 192 1 elsevier elsevier PROPN iajs-312 192 2 limited limited PROPN iajs-312 192 3 . . PUNCT iajs-312 192 4                                 SPACE iajs-312 193 1 27 27 NUM iajs-312 193 2 - - PUNCT iajs-312 193 3 anthony anthony PROPN iajs-312 193 4 r.m r.m PROPN iajs-312 193 5 ; ; PUNCT iajs-312 193 6 t. t. PROPN iajs-312 193 7 kobayashi kobayashi PROPN iajs-312 193 8 ; ; PUNCT iajs-312 193 9 f. f. PROPN iajs-312 193 10 ermeling ermeling PROPN iajs-312 193 11 and and CCONJ iajs-312 193 12 j.v j.v PROPN iajs-312 193 13 . . PUNCT iajs-312 193 14 ravetch.(2011 ravetch.(2011 NOUN iajs-312 193 15 ) ) PUNCT iajs-312 193 16 . . PUNCT iajs-312 194 1 intravenous intravenous ADJ iajs-312 194 2 gammaglobulin gammaglobulin PROPN iajs-312 194 3 suppresses suppress VERB iajs-312 194 4 inflammation inflammation NOUN iajs-312 194 5 through through ADP iajs-312 194 6 a a DET iajs-312 194 7 novel novel NOUN iajs-312 194 8 t(h)2 t(h)2 ADP iajs-312 194 9 pathway pathway NOUN iajs-312 194 10 . . PUNCT iajs-312 195 1 nature nature PROPN iajs-312 195 2 475:110 475:110 PROPN iajs-312 195 3 – – PUNCT iajs-312 195 4 113 113 NUM iajs-312 195 5 . . PUNCT iajs-312 195 6 table table NOUN iajs-312 196 1 no no INTJ iajs-312 196 2 . . PUNCT iajs-312 197 1 ( ( PUNCT iajs-312 197 2 1):level 1):level NUM iajs-312 197 3 of of ADP iajs-312 197 4 sialic sialic ADJ iajs-312 197 5 acid acid NOUN iajs-312 197 6 , , PUNCT iajs-312 197 7 pon1and pon1and NOUN iajs-312 197 8 igg igg PROPN iajs-312 197 9 in in ADP iajs-312 197 10 sera sera NOUN iajs-312 197 11 of of ADP iajs-312 197 12 the the DET iajs-312 197 13 studied study VERB iajs-312 197 14 groups group NOUN iajs-312 197 15 . . PUNCT iajs-312 198 1 p p NOUN iajs-312 198 2 values value NOUN iajs-312 198 3 < < X iajs-312 198 4 0.05 0.05 NUM iajs-312 198 5 considered consider VERB iajs-312 198 6 significant significant ADJ iajs-312 198 7 ( ( PUNCT iajs-312 198 8 s s NOUN iajs-312 198 9 ) ) PUNCT iajs-312 198 10                                                                                                                                                                         SPACE iajs-312 198 11 p p NOUN iajs-312 198 12 values value NOUN iajs-312 198 13 < < X iajs-312 198 14 0.001 0.001 NUM iajs-312 198 15 considered consider VERB iajs-312 198 16 high high ADJ iajs-312 198 17 significant significant ADJ iajs-312 198 18 ( ( PUNCT iajs-312 198 19 hs hs NOUN iajs-312 198 20 ) ) PUNCT iajs-312 198 21     SPACE iajs-312 199 1 p p NOUN iajs-312 199 2 values value NOUN iajs-312 199 3 > > X iajs-312 199 4 0.05 0.05 NUM iajs-312 199 5 considered consider VERB iajs-312 199 6 nonsignificant nonsignificant ADJ iajs-312 199 7 ( ( PUNCT iajs-312 199 8 ns ns NUM iajs-312 199 9 ) ) PUNCT iajs-312 199 10 g1vs g1vs NOUN iajs-312 199 11 g4 g4 NOUN iajs-312 199 12 g1vs g1vs NOUN iajs-312 199 13 g3 g3 PROPN iajs-312 199 14 g1vs g1vs NOUN iajs-312 199 15 g2 g2 PROPN iajs-312 199 16 mean mean VERB iajs-312 199 17 ±sem ±sem ADJ iajs-312 199 18 g4 g4 NOUN iajs-312 199 19 mean mean VERB iajs-312 199 20 ±sem ±sem PROPN iajs-312 199 21 g3 g3 PROPN iajs-312 199 22 mean mean PROPN iajs-312 199 23 ±sem ±sem PROPN iajs-312 199 24 g2 g2 PROPN iajs-312 199 25 mean mean VERB iajs-312 199 26 ±sem ±sem AUX iajs-312 199 27 g1 g1 PROPN iajs-312 199 28 paramet paramet VERB iajs-312 199 29 er er INTJ iajs-312 199 30 s s VERB iajs-312 199 31 ns ns NUM iajs-312 199 32 s s PROPN iajs-312 199 33 13.66 13.66 NUM iajs-312 199 34 ±2.733 ±2.733 NOUN iajs-312 199 35 10.25±2.05 10.25±2.05 NUM iajs-312 199 36 1 1 NUM iajs-312 199 37 10.05±2.01 10.05±2.01 NUM iajs-312 199 38 1 1 NUM iajs-312 199 39 7.17±1.434 7.17±1.434 NUM iajs-312 199 40 sialic sialic ADJ iajs-312 199 41 acid acid NOUN iajs-312 199 42 ns ns NUM iajs-312 199 43 ns ns PROPN iajs-312 199 44 hs hs PROPN iajs-312 199 45 324.25±64 324.25±64 PROPN iajs-312 199 46 . . PROPN iajs-312 199 47 85 85 NUM iajs-312 199 48 321.56±64 321.56±64 NUM iajs-312 199 49 . . PUNCT iajs-312 200 1 313 313 NUM iajs-312 200 2 174.77±34 174.77±34 NUM iajs-312 200 3 . . PUNCT iajs-312 201 1 955 955 NUM iajs-312 201 2 397.8±79.5 397.8±79.5 NUM iajs-312 201 3 68 68 NUM iajs-312 201 4 pon-1 pon-1 X iajs-312 201 5 s s NOUN iajs-312 201 6 ns ns NUM iajs-312 201 7 ns ns NUM iajs-312 201 8 590.4±241 590.4±241 NUM iajs-312 201 9 . . PUNCT iajs-312 201 10 50 50 NUM iajs-312 201 11 513.9±102 513.9±102 NUM iajs-312 201 12 . . PUNCT iajs-312 201 13 78 78 NUM iajs-312 201 14 493.08±98 493.08±98 NUM iajs-312 201 15 . . PUNCT iajs-312 202 1 61 61 NUM iajs-312 202 2 450.11±90 450.11±90 NUM iajs-312 202 3 . . PUNCT iajs-312 203 1 02 02 NUM iajs-312 203 2 igg igg PROPN iajs-312 203 3 476 476 NUM iajs-312 203 4 | | ADV iajs-312 203 5 chemistry chemistry NOUN iajs-312 203 6 2014 2014 NUM iajs-312 203 7 ) ) PUNCT iajs-312 203 8 عام عام ADP iajs-312 203 9 3(العدد 3(العدد NUM iajs-312 203 10 27المجلد 27المجلد NUM iajs-312 203 11 مجلة مجلة VERB iajs-312 203 12 إبن إبن NOUN iajs-312 203 13 الھيثم الھيثم NOUN iajs-312 203 14 للعلوم للعلوم NOUN iajs-312 203 15 الصرفة الصرفة NOUN iajs-312 204 1 و و PRON iajs-312 204 2 التطبيقية التطبيقية ADJ iajs-312 204 3 ibn ibn PROPN iajs-312 204 4 al al PROPN iajs-312 204 5 - - PUNCT iajs-312 204 6 haitham haitham PROPN iajs-312 204 7 jour jour X iajs-312 204 8 . . PROPN iajs-312 204 9 for for ADP iajs-312 204 10 pure pure ADJ iajs-312 204 11 & & CCONJ iajs-312 204 12 appl appl PROPN iajs-312 204 13 . . PUNCT iajs-312 205 1 sci sci PROPN iajs-312 205 2 . . PUNCT iajs-312 205 3 vol vol NOUN iajs-312 205 4 . . PROPN iajs-312 206 1 27 27 NUM iajs-312 206 2 ( ( PUNCT iajs-312 206 3 3 3 NUM iajs-312 206 4 ) ) PUNCT iajs-312 206 5 2014 2014 NUM iajs-312 206 6 table table NOUN iajs-312 206 7 no no INTJ iajs-312 206 8 . . PUNCT iajs-312 207 1 ( ( PUNCT iajs-312 207 2 2 2 NUM iajs-312 207 3 ): ): PUNCT iajs-312 207 4 correlation correlation NOUN iajs-312 207 5 relation relation NOUN iajs-312 207 6 analysis analysis NOUN iajs-312 207 7 between between ADP iajs-312 207 8 biochemical biochemical ADJ iajs-312 207 9 parameters parameter NOUN iajs-312 207 10 among among ADP iajs-312 207 11 three three NUM iajs-312 207 12 studied study VERB iajs-312 207 13 groups group NOUN iajs-312 207 14 . . PUNCT iajs-312 208 1 g4 g4 NOUN iajs-312 208 2 g3 g3 NOUN iajs-312 208 3 g2 g2 PROPN iajs-312 208 4 r r NOUN iajs-312 208 5 & & CCONJ iajs-312 208 6 p p NOUN iajs-312 208 7 parameter parameter NOUN iajs-312 208 8 0.0190.2970.158r 0.0190.2970.158r NUM iajs-312 208 9 sialic sialic ADJ iajs-312 208 10 & & CCONJ iajs-312 208 11 months month NOUN iajs-312 208 12 p>0.05p>0.05p>0.05p p>0.05p>0.05p>0.05p PROPN iajs-312 208 13 0.071 0.071 NUM iajs-312 208 14 0.0330.123 0.0330.123 NUM iajs-312 208 15 r r NOUN iajs-312 208 16 pon-1 pon-1 NOUN iajs-312 208 17 & & CCONJ iajs-312 208 18 months month NOUN iajs-312 208 19 p>0.05 p>0.05 PROPN iajs-312 208 20 p>0.05p>0.05p p>0.05p>0.05p PROPN iajs-312 208 21 0.1400.0890.143r 0.1400.0890.143r NUM iajs-312 208 22 igg igg PROPN iajs-312 208 23 & & CCONJ iajs-312 208 24 months months PROPN iajs-312 208 25 p<0.05p>0.05p>0.05 p<0.05p>0.05p>0.05 PROPN iajs-312 208 26 p p PROPN iajs-312 208 27 p p PROPN iajs-312 208 28 values value NOUN iajs-312 208 29 < < X iajs-312 208 30 0.05 0.05 NUM iajs-312 208 31 considered consider VERB iajs-312 208 32 significant significant ADJ iajs-312 208 33 ( ( PUNCT iajs-312 208 34 s s NOUN iajs-312 208 35 ) ) PUNCT iajs-312 208 36 p p NOUN iajs-312 208 37 values value NOUN iajs-312 208 38 < < X iajs-312 208 39 0.001 0.001 NUM iajs-312 208 40 considered consider VERB iajs-312 208 41 high high ADJ iajs-312 208 42 significant significant ADJ iajs-312 208 43 ( ( PUNCT iajs-312 208 44 hs hs NOUN iajs-312 208 45 ) ) PUNCT iajs-312 208 46                                                                                                                                         SPACE iajs-312 208 47 p p PROPN iajs-312 208 48 values>0.05 values>0.05 PROPN iajs-312 208 49 considered consider VERB iajs-312 208 50 nonsignificant nonsignificant ADJ iajs-312 208 51 ( ( PUNCT iajs-312 208 52 ns ns NUM iajs-312 208 53 ) ) PUNCT iajs-312 208 54                                                                                                                                                 SPACE iajs-312 208 55 r r NOUN iajs-312 208 56 values value NOUN iajs-312 208 57 mean mean VERB iajs-312 208 58 correlation correlation NOUN iajs-312 208 59 coefficient coefficient PROPN iajs-312 208 60 figuer figuer PROPN iajs-312 208 61 no.(1 no.(1 PROPN iajs-312 208 62 ): ): PUNCT iajs-312 208 63 correlation correlation NOUN iajs-312 208 64 between between ADP iajs-312 208 65 sialic sialic ADJ iajs-312 208 66 acid acid NOUN iajs-312 208 67 and and CCONJ iajs-312 208 68 duration duration NOUN iajs-312 208 69 of of ADP iajs-312 208 70 disease disease NOUN iajs-312 208 71 in in ADP iajs-312 208 72 months month NOUN iajs-312 208 73 . . PUNCT iajs-312 209 1 477 477 NUM iajs-312 210 1 | | ADV iajs-312 210 2 chemistry chemistry NOUN iajs-312 210 3 2014 2014 NUM iajs-312 210 4 ) ) PUNCT iajs-312 210 5 عام عام ADP iajs-312 210 6 3(العدد 3(العدد NUM iajs-312 210 7 27المجلد 27المجلد NUM iajs-312 210 8 مجلة مجلة VERB iajs-312 210 9 إبن إبن NOUN iajs-312 210 10 الھيثم الھيثم NOUN iajs-312 210 11 للعلوم للعلوم NOUN iajs-312 210 12 الصرفة الصرفة NOUN iajs-312 211 1 و و PRON iajs-312 211 2 التطبيقية التطبيقية ADJ iajs-312 211 3 ibn ibn PROPN iajs-312 211 4 al al PROPN iajs-312 211 5 - - PUNCT iajs-312 211 6 haitham haitham PROPN iajs-312 211 7 jour jour X iajs-312 211 8 . . PROPN iajs-312 211 9 for for ADP iajs-312 211 10 pure pure ADJ iajs-312 211 11 & & CCONJ iajs-312 211 12 appl appl PROPN iajs-312 211 13 . . PUNCT iajs-312 212 1 sci sci PROPN iajs-312 212 2 . . PUNCT iajs-312 212 3 vol vol NOUN iajs-312 212 4 . . PROPN iajs-312 213 1 27 27 NUM iajs-312 213 2 ( ( PUNCT iajs-312 213 3 3 3 NUM iajs-312 213 4 ) ) PUNCT iajs-312 213 5 2014 2014 NUM iajs-312 213 6 figuer figuer NOUN iajs-312 213 7 no.(2 no.(2 NOUN iajs-312 213 8 ): ): PUNCT iajs-312 213 9 correlation correlation NOUN iajs-312 213 10 between between ADP iajs-312 213 11 pon1 pon1 NOUN iajs-312 213 12 and and CCONJ iajs-312 213 13 duration duration NOUN iajs-312 213 14 of of ADP iajs-312 213 15 disease disease NOUN iajs-312 213 16 in in ADP iajs-312 213 17 months month NOUN iajs-312 213 18 . . PUNCT iajs-312 214 1 correlation correlation NOUN iajs-312 214 2 between between ADP iajs-312 214 3 igg igg PROPN iajs-312 214 4 and and CCONJ iajs-312 214 5 duration duration NOUN iajs-312 214 6 of of ADP iajs-312 214 7 disease disease NOUN iajs-312 214 8 in in ADP iajs-312 214 9 months month NOUN iajs-312 214 10 . . PUNCT iajs-312 215 1 : : PUNCT iajs-312 215 2 figure figure VERB iajs-312 215 3 no(3 no(3 PROPN iajs-312 215 4 ) ) PUNCT iajs-312 215 5 478 478 NUM iajs-312 216 1 | | ADV iajs-312 216 2 chemistry chemistry NOUN iajs-312 216 3 2014 2014 NUM iajs-312 216 4 ) ) PUNCT iajs-312 216 5 عام عام ADP iajs-312 216 6 3(العدد 3(العدد NUM iajs-312 216 7 27المجلد 27المجلد NUM iajs-312 216 8 مجلة مجلة VERB iajs-312 216 9 إبن إبن NOUN iajs-312 216 10 الھيثم الھيثم NOUN iajs-312 216 11 للعلوم للعلوم NOUN iajs-312 216 12 الصرفة الصرفة NOUN iajs-312 217 1 و و PRON iajs-312 217 2 التطبيقية التطبيقية ADJ iajs-312 217 3 ibn ibn PROPN iajs-312 217 4 al al PROPN iajs-312 217 5 - - PUNCT iajs-312 217 6 haitham haitham PROPN iajs-312 217 7 jour jour X iajs-312 217 8 . . PROPN iajs-312 217 9 for for ADP iajs-312 217 10 pure pure ADJ iajs-312 217 11 & & CCONJ iajs-312 217 12 appl appl PROPN iajs-312 217 13 . . PUNCT iajs-312 218 1 sci sci PROPN iajs-312 218 2 . . PUNCT iajs-312 218 3 vol vol NOUN iajs-312 218 4 . . PROPN iajs-312 219 1 27 27 NUM iajs-312 219 2 ( ( PUNCT iajs-312 219 3 3 3 NUM iajs-312 219 4 ) ) PUNCT iajs-312 219 5 2014 2014 NUM iajs-312 219 6 والكلوبيولين والكلوبيولين NOUN iajs-312 219 7 -1الباروكسينيز -1الباروكسينيز PUNCT iajs-312 219 8 وانزيم وانزيم PROPN iajs-312 219 9 السياليك السياليك PROPN iajs-312 219 10 حامض حامض PROPN iajs-312 219 11 مستوى مستوى PROPN iajs-312 219 12 تقدير تقدير PROPN iajs-312 219 13 ميسان ميسان NOUN iajs-312 219 14 في في ADP iajs-312 219 15 المبايض المبايض NOUN iajs-312 219 16 تكيس تكيس PROPN iajs-312 219 17 متالزمة متالزمة PROPN iajs-312 219 18 مريضات مريضات PROPN iajs-312 219 19 في في ADP iajs-312 219 20 g g PROPN iajs-312 219 21 المناعي المناعي PROPN iajs-312 219 22 محيسن محيسن PROPN iajs-312 219 23 كريم كريم PROPN iajs-312 219 24 إبتسام إبتسام PROPN iajs-312 219 25 االسنان االسنان PROPN iajs-312 219 26 / / SYM iajs-312 219 27 جامعة جامعة PROPN iajs-312 219 28 ميسانكلية ميسانكلية NOUN iajs-312 219 29 طب طب PROPN iajs-312 219 30 المشھداني المشھداني PROPN iajs-312 219 31 ابراھيم ابراھيم PROPN iajs-312 219 32 زھير زھير PROPN iajs-312 219 33 علي علي NOUN iajs-312 219 34 حميد حميد PROPN iajs-312 219 35 بشرى بشرى NOUN iajs-312 219 36 بغداد بغداد NOUN iajs-312 219 37 جامعة/ جامعة/ NUM iajs-312 219 38 الھيثم الھيثم NOUN iajs-312 219 39 ) ) PUNCT iajs-312 219 40 ( ( PUNCT iajs-312 219 41 أبن/ أبن/ NOUN iajs-312 219 42 الصرفة الصرفة NOUN iajs-312 219 43 للعلوم للعلوم PROPN iajs-312 219 44 التربية التربية PROPN iajs-312 219 45 كلية كلية PROPN iajs-312 219 46 / / SYM iajs-312 219 47 الكيمياء الكيمياء PROPN iajs-312 219 48 قسم قسم PROPN iajs-312 219 49 2014تشرين 2014تشرين NOUN iajs-312 219 50 االول االول ADP iajs-312 219 51 20 20 NUM iajs-312 219 52 , , PUNCT iajs-312 219 53 قبل قبل PROPN iajs-312 219 54 البحث البحث VERB iajs-312 219 55 في في ADP iajs-312 220 1 : : PUNCT iajs-312 220 2 2014ايار20البحث 2014ايار20البحث NUM iajs-312 220 3 في في NOUN iajs-312 220 4 : : PUNCT iajs-312 220 5 استلم استلم PROPN iajs-312 220 6 الخالصة الخالصة PROPN iajs-312 221 1 ذا ذا PRON iajs-312 221 2 . . PUNCT iajs-312 222 1 متجانس متجانس PROPN iajs-312 222 2 غير غير VERB iajs-312 222 3 اضطراب اضطراب PROPN iajs-312 222 4 ھو ھو PROPN iajs-312 222 5 المبايض المبايض VERB iajs-312 222 6 تكيس تكيس PROPN iajs-312 222 7 متالزمة متالزمة PROPN iajs-312 222 8 ؤثر ؤثر PROPN iajs-312 223 1 المرض المرض INTJ iajs-312 223 2 وھ وھ NOUN iajs-312 223 3 ي ي PROPN iajs-312 223 4 ي ي X iajs-312 223 5 اء اء INTJ iajs-312 224 1 من من NUM iajs-312 224 2 % % NOUN iajs-312 224 3 10 10 NUM iajs-312 224 4 - - SYM iajs-312 224 5 6 6 NUM iajs-312 224 6 ف ف NOUN iajs-312 224 7 اتھم اتھم PROPN iajs-312 224 8 خالل خالل PROPN iajs-312 224 9 النس النس PROPN iajs-312 225 1 حي حي X iajs-312 225 2 ر ر DET iajs-312 225 3 يكونون يكونون PROPN iajs-312 225 4 المبايض المبايض VERB iajs-312 225 5 تكيس تكيس VERB iajs-312 225 6 من من PROPN iajs-312 225 7 يعانون يعانون PROPN iajs-312 225 8 الذين الذين PROPN iajs-312 225 9 المرضى المرضى PROPN iajs-312 225 10 . . PUNCT iajs-312 226 1 االنجابية االنجابية PROPN iajs-312 226 2 أمراض أمراض PROPN iajs-312 226 3 لالصابة لالصابة PROPN iajs-312 226 4 عرضة عرضة NOUN iajs-312 226 5 اكث اكث PRON iajs-312 226 6 ة ة ADP iajs-312 226 7 القلب القلب ADJ iajs-312 226 8 ب ب DET iajs-312 226 9 دھون دھون PROPN iajs-312 226 10 بسبب بسبب VERB iajs-312 226 11 التاجي التاجي NOUN iajs-312 226 12 ال ال ADP iajs-312 226 13 ى ى PROPN iajs-312 226 14 تھدف تھدف NOUN iajs-312 226 15 الحالية الحالية ADP iajs-312 226 16 الدراسة.والبدانة الدراسة.والبدانة NUM iajs-312 226 17 االنسولين االنسولين NOUN iajs-312 226 18 ومقاومة ومقاومة NOUN iajs-312 226 19 الطبيعية الطبيعية PROPN iajs-312 226 20 غير غير VERB iajs-312 226 21 ليط ليط VERB iajs-312 226 22 ال ال ADP iajs-312 226 23 ى ى PRON iajs-312 226 24 الضوء الضوء X iajs-312 226 25 تس تس INTJ iajs-312 226 26 اھمة اھمة NOUN iajs-312 226 27 عل عل ADP iajs-312 226 28 ياليك ياليك PROPN iajs-312 226 29 حامض حامض NOUN iajs-312 226 30 مس مس ADP iajs-312 226 31 زيم زيم PROPN iajs-312 226 32 الس الس PROPN iajs-312 226 33 وان وان PROPN iajs-312 226 34 مريضة مريضة NOUN iajs-312 226 35 75 75 NUM iajs-312 226 36 اخذ اخذ NOUN iajs-312 226 37 تم تم NOUN iajs-312 226 38 . . PUNCT iajs-312 227 1 المبايض المبايض PROPN iajs-312 227 2 تكيس تكيس VERB iajs-312 227 3 بمتالزمة بمتالزمة ADJ iajs-312 227 4 التسبب التسبب PROPN iajs-312 227 5 في في ADP iajs-312 227 6 سريرية سريرية NOUN iajs-312 227 7 بايولوجية بايولوجية PROPN iajs-312 227 8 عالمات عالمات VERB iajs-312 227 9 g g PROPN iajs-312 227 10 المناعي المناعي PROPN iajs-312 227 11 والكلوبيولين والكلوبيولين PROPN iajs-312 227 12 الباروكسينيز الباروكسينيز PROPN iajs-312 228 1 2013 2013 NUM iajs-312 228 2 تموز تموز PROPN iajs-312 228 3 من من PROPN iajs-312 228 4 للمدة للمدة PROPN iajs-312 228 5 ميسان ميسان NOUN iajs-312 228 6 محافظة محافظة PROPN iajs-312 228 7 في في ADP iajs-312 228 8 الجراحي الجراحي PROPN iajs-312 228 9 الزھراوي الزھراوي PROPN iajs-312 228 10 ومستشفى ومستشفى PROPN iajs-312 228 11 التعليمي التعليمي AUX iajs-312 228 12 الصدر الصدر VERB iajs-312 228 13 مستشفى مستشفى PROPN iajs-312 228 14 من من PROPN iajs-312 228 15 سنة سنة NOUN iajs-312 228 16 ) ) PUNCT iajs-312 228 17 38 38 NUM iajs-312 228 18 - - SYM iajs-312 228 19 16 16 NUM iajs-312 228 20 ( ( PUNCT iajs-312 228 21 بعمر بعمر NOUN iajs-312 228 22 ذلك ذلك VERB iajs-312 228 23 2013 2013 NUM iajs-312 228 24 االول االول NOUN iajs-312 228 25 كانون كانون NOUN iajs-312 228 26 الى الى VERB iajs-312 228 27 ى ى PROPN iajs-312 228 28 مجموعة مجموعة PROPN iajs-312 228 29 وعدت وعدت NOUN iajs-312 228 30 السيطرة السيطرة PROPN iajs-312 228 31 مجموعة مجموعة PROPN iajs-312 228 32 وك وك PROPN iajs-312 228 33 ى ى DET iajs-312 228 34 المرضية المرضية ADJ iajs-312 228 35 الحاالت الحاالت PROPN iajs-312 228 36 قسمت قسمت PROPN iajs-312 228 37 . . PUNCT iajs-312 229 1 اول اول VERB iajs-312 229 2 اميع اميع PROPN iajs-312 229 3 ثالث ثالث NOUN iajs-312 229 4 عل عل ADP iajs-312 229 5 مج مج PROPN iajs-312 229 6 ى ى PROPN iajs-312 229 7 اشھر اشھر ADJ iajs-312 229 8 3 3 NUM iajs-312 229 9 من من NOUN iajs-312 229 10 المدة المدة NOUN iajs-312 229 11 أذ أذ PROPN iajs-312 229 12 عدت عدت PROPN iajs-312 229 13 , , PUNCT iajs-312 229 14 المبايض المبايض VERB iajs-312 229 15 تكيس تكيس PROPN iajs-312 229 16 متالزمة متالزمة PROPN iajs-312 229 17 بمرض بمرض NOUN iajs-312 229 18 االصابة االصابة NOUN iajs-312 229 19 مدة مدة NUM iajs-312 229 20 على على PROPN iajs-312 229 21 باالعتماد باالعتماد NOUN iajs-312 229 22 ى ى PROPN iajs-312 229 23 شھراَمجموعة شھراَمجموعة NUM iajs-312 229 24 12 12 NUM iajs-312 229 25 ال ال NOUN iajs-312 229 26 ومن ومن PROPN iajs-312 229 27 , , PUNCT iajs-312 229 28 اول اول VERB iajs-312 229 29 ھراَ ھراَ PROPN iajs-312 229 30 24 24 NUM iajs-312 229 31 الى الى PROPN iajs-312 229 32 شھراَ شھراَ NUM iajs-312 229 33 12 12 NUM iajs-312 229 34 ة ة PRON iajs-312 229 35 مجموعة مجموعة NOUN iajs-312 229 36 ش ش PROPN iajs-312 229 37 دة دة PROPN iajs-312 229 38 , , PUNCT iajs-312 229 39 ثاني ثاني PROPN iajs-312 229 40 ى ى X iajs-312 229 41 شھراَ شھراَ PROPN iajs-312 229 42 24 24 NUM iajs-312 229 43 من من NOUN iajs-312 229 44 والم والم NOUN iajs-312 229 45 ر ر PROPN iajs-312 229 46 شھر شھر VERB iajs-312 230 1 48 48 NUM iajs-312 230 2 ال ال NOUN iajs-312 230 3 ة ة DET iajs-312 230 4 مجموعة مجموعة PROPN iajs-312 230 5 وأكث وأكث PROPN iajs-312 230 6 م م PROPN iajs-312 230 7 . . PUNCT iajs-312 230 8 رابع رابع NOUN iajs-312 230 9 دير دير PROPN iajs-312 230 10 التشخيص التشخيص VERB iajs-312 230 11 ت ت PRON iajs-312 230 12 بتق بتق PROPN iajs-312 230 13 ياليك ياليك VERB iajs-312 230 14 حامض حامض PROPN iajs-312 230 15 مستوى مستوى PROPN iajs-312 230 16 زيم زيم PROPN iajs-312 230 17 الس الس PROPN iajs-312 230 18 ينيز ينيز PROPN iajs-312 230 19 وان وان PROPN iajs-312 230 20 ولين ولين PROPN iajs-312 230 21 الباروكس الباروكس VERB iajs-312 230 22 اعي اعي NOUN iajs-312 230 23 والكلوبي والكلوبي ADJ iajs-312 230 24 ائج ائج NOUN iajs-312 230 25 وجود وجود NOUN iajs-312 230 26 g g PROPN iajs-312 230 27 المن المن PROPN iajs-312 230 28 اميع اميع PROPN iajs-312 230 29 المدروسة المدروسة PROPN iajs-312 230 30 وبينت وبينت NOUN iajs-312 230 31 النت النت VERB iajs-312 230 32 ي ي X iajs-312 230 33 كل كل PROPN iajs-312 230 34 المج المج PROPN iajs-312 230 35 ف ف PROPN iajs-312 230 36 تنتج تنتج PROPN iajs-312 230 37 اجريت اجريت VERB iajs-312 230 38 التي التي PROPN iajs-312 230 39 الدراسة الدراسة PROPN iajs-312 230 40 ھذه ھذه PROPN iajs-312 230 41 ومن ومن PROPN iajs-312 230 42 . . PUNCT iajs-312 231 1 gالمناعي gالمناعي ADJ iajs-312 231 2 , , PUNCT iajs-312 231 3 والكلوبيولين والكلوبيولين PROPN iajs-312 231 4 الباروكسينيز الباروكسينيز PROPN iajs-312 231 5 , , PUNCT iajs-312 231 6 و و PRON iajs-312 231 7 السياليك السياليك NOUN iajs-312 231 8 حامض حامض PROPN iajs-312 231 9 بمستوى بمستوى PROPN iajs-312 231 10 جوھري جوھري NOUN iajs-312 231 11 ارتفاع ارتفاع PROPN iajs-312 231 12 نس نس PROPN iajs-312 231 13 اع اع PROPN iajs-312 231 14 أن أن AUX iajs-312 231 15 توى توى PROPN iajs-312 231 16 ارتف ارتف PROPN iajs-312 231 17 ز ز ADP iajs-312 231 18 مس مس X iajs-312 231 19 زيم زيم NOUN iajs-312 231 20 تركي تركي PROPN iajs-312 232 1 ياليك ياليك PROPN iajs-312 232 2 وان وان PROPN iajs-312 232 3 امض امض PROPN iajs-312 232 4 الس الس PROPN iajs-312 232 5 ينيز ينيز PROPN iajs-312 232 6 ح ح PROPN iajs-312 232 7 ولين ولين PROPN iajs-312 232 8 الباروكس الباروكس VERB iajs-312 232 9 اعي اعي NOUN iajs-312 232 10 والكلوبي والكلوبي PROPN iajs-312 232 11 ن ن X iajs-312 232 12 g g NOUN iajs-312 232 13 المن المن NOUN iajs-312 233 1 وء وء INTJ iajs-312 233 2 ان ان ADV iajs-312 233 3 يمك يمك PROPN iajs-312 233 4 ي ي NUM iajs-312 233 5 التنب التنب NOUN iajs-312 234 1 اھم اھم PROPN iajs-312 234 2 ف ف X iajs-312 234 3 يس يس PROPN iajs-312 234 4 باالصابه باالصابه PROPN iajs-312 234 5 بمرض بمرض X iajs-312 234 6 تكيس تكيس VERB iajs-312 234 7 المبايض المبايض PROPN iajs-312 234 8 . . PUNCT iajs-312 235 1 gالمبايض gالمبايض PROPN iajs-312 235 2 , , PUNCT iajs-312 235 3 حامض حامض PROPN iajs-312 235 4 السياليك السياليك PROPN iajs-312 235 5 , , PUNCT iajs-312 235 6 انزيم انزيم PROPN iajs-312 235 7 الباروكسينيز الباروكسينيز PROPN iajs-312 235 8 , , PUNCT iajs-312 235 9 والكلوبيولين والكلوبيولين PROPN iajs-312 235 10 المناعي المناعي PROPN iajs-312 235 11 تكيس تكيس PROPN iajs-312 235 12 -الكلمات -الكلمات PROPN iajs-312 235 13 المفتاحية المفتاحية NOUN iajs-312 235 14 : : PUNCT